☰

Timothy Rebbeck - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Epidemiology
Tree Info Similar researchers PubMed Report error

175/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, Darst BF, Sheng X, Xu Y, Chou AJ, Benlloch S, Dadaev T, Brook MN, Plym A, Sahimi A, ... ... Rebbeck TR, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics. PMID 37945903 DOI: 10.1038/s41588-023-01534-4  0.334
2023 Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, Wang A, Shen J, Saunders EJ, Rhie SK, Bensen JT, Ingles SA, Kittles RA, Strom SS, Rybicki BA, ... ... Rebbeck TR, et al. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. European Urology. PMID 36872133 DOI: 10.1016/j.eururo.2023.01.022  0.307
2022 Friebel-Klingner TM, Bazzett-Matabele L, Ramogola-Masire D, Monare B, Ralefala TB, Seiphetlheng A, Ramontshonyana G, Vuylsteke P, Mitra N, Wiebe DJ, Rebbeck TR, McCarthy AM, Grover S. Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV. Jco Global Oncology. 8: e2200183. PMID 36395437 DOI: 10.1200/GO.22.00183  0.454
2022 Kim MS, Naidoo D, Hazra U, Quiver MH, Chen WC, Simonti CN, Kachambwa P, Harlemon M, Agalliu I, Baichoo S, Fernandez P, Hsing AW, Jalloh M, Gueye SM, Niang L, ... ... Rebbeck TR, et al. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa. Genome Biology. 23: 194. PMID 36100952 DOI: 10.1186/s13059-022-02766-z  0.322
2022 Friebel-Klingner TM, Iyer HS, Ramogola-Masire D, Bazzett-Matabele L, Monare B, Seiphetlheng A, Ralefala TB, Mitra N, Wiebe DJ, Rebbeck TR, Grover S, McCarthy AM. Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana. Plos One. 17: e0271679. PMID 35925976 DOI: 10.1371/journal.pone.0271679  0.459
2022 Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, Nielsen HR, Lee A, Yang X, McGuffog L, Parsons MT, Andrulis IL, Arnold N, Belotti M, Borg Å, et al. Cancer Risks Associated With and Pathogenic Variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102112. PMID 35077220 DOI: 10.1200/JCO.21.02112  0.324
2022 Darst BF, Hughley R, Pfennig A, Hazra U, Fan C, Wan P, Sheng X, Xia L, Andrews C, Chen F, Berndt SI, Kote-Jarai Z, Govindasami K, Bensen JT, Ingles SA, ... ... Rebbeck TR, et al. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. European Urology. PMID 35031163 DOI: 10.1016/j.eururo.2021.12.023  0.326
2021 Friebel-Klingner TM, Luckett R, Bazzett-Matabele L, Ralefala TB, Monare B, Nassali MN, Ramogola-Masire D, Bvochora M, Mitra N, Wiebe D, Rebbeck TR, McCarthy AM, Grover S. Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana. Bmc Women's Health. 21: 267. PMID 34229672 DOI: 10.1186/s12905-021-01402-5  0.469
2021 Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, Markt SC, Freedman M, Pomerantz M, Lee GM, Rana H, Börnigen D, Rebbeck TR, Huttenhower C, Eeles RA, et al. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. The Prostate. PMID 33956343 DOI: 10.1002/pros.24148  0.304
2021 Han D, Owiredu JN, Healy BM, Li M, Labaf M, Steinfeld JS, Patalano S, Gao S, Liu M, Macoska JA, Zarringhalam K, Siegfried KR, Yuan X, Rebbeck TR, Cai C. Susceptibility-associated genetic variation in NEDD9 contributes to prostate cancer initiation and progression. Cancer Research. PMID 33632899 DOI: 10.1158/0008-5472.CAN-20-3042  0.328
2020 Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... ... Rebbeck TR, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739  0.312
2020 Silvestri V, Leslie G, Barnes DR, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, ... ... Rebbeck TR, et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Jama Oncology. PMID 32614418 DOI: 10.1001/Jamaoncol.2020.2134  0.336
2020 Fadelu T, Damuse R, Lormil J, Pecan E, Dubuisson C, Pierre V, Rebbeck T, Shulman LN. Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort. The Oncologist. PMID 32584461 DOI: 10.1634/Theoncologist.2019-0951  0.36
2020 Harlemon M, Ajayi O, Kachambwa P, Kim MS, Simonti CN, Quiver MH, Petersen DC, Mittal A, Fernandez PW, Hsing AW, Baichoo S, Agalliu I, Jalloh M, Gueye SM, Snyper NYF, ... ... Rebbeck TR, et al. A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa. Cancer Research. PMID 32393663 DOI: 10.1158/0008-5472.CAN-19-2165  0.337
2020 Kensler K, Pernar C, Mahal B, Nguyen P, Trinh Q, Kibel A, Rebbeck T. PSA Testing and Prostate Cancer Incidence Following the 2012 Update to the U.S. Preventive Services Task Force Prostate Cancer Screening Recommendation: Implications for Racial/Ethnic Disparities Cancer Epidemiology Biomarkers & Prevention. 29: 694.1-694. DOI: 10.1158/1055-9965.Epi-20-0066  0.384
2019 Patel VL, Busch EL, Friebel TM, Cronin A, Leslie G, McGuffog L, Adlard J, Agata S, Agnarsson BA, Ahmed M, Aittomäki K, Alducci E, Andrulis IL, Arason A, Arnold N, ... ... Rebbeck TR, et al. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. Cancer Research. PMID 31723001 DOI: 10.1158/0008-5472.Can-19-1840  0.314
2019 Hamajima N, Hirose K, Tajima K, Rohan T, Friedenreich C, Gapstur S, Gaudet M, Coates R, Liff J, Kakouri E, Marcou Y, Duffy S, Morabia A, Schuman L, Stewart W, ... ... Rebbeck T, et al. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence The Lancet. 394: 1159-1168. PMID 31474332 DOI: 10.1016/S0140-6736(19)31709-X  0.37
2019 Mahal AR, Butler S, Franco I, Muralidhar V, Larios D, Pike LRG, Zhao SG, Sanford NN, Dess RT, Feng FY, D'Amico AV, Spratt DE, Yu JB, Nguyen PL, Rebbeck TR, et al. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Cancer. PMID 31251398 DOI: 10.1200/Jco.2019.37.7_Suppl.12  0.346
2019 Lu-Yao GL, Nikita N, Keith SW, Banks J, Handley N, Rebbeck T, Cullen J, Domingo-Domenech J, Kelly WK. Racial differences in long-term prostate cancer specific mortality following conservative management for low-risk prostate cancer: A population-based study. Journal of Clinical Oncology. 37: 121-121. DOI: 10.1200/Jco.2019.37.7_Suppl.121  0.413
2019 Butler S, Franco II, Mahal AR, Sanford NN, Trinh Q, Rebbeck T, Nguyen PL, D'Amico AV, Mahal BAV. “Management Migration” in United States patients diagnosed with localized prostate cancer from 2010-2015. Journal of Clinical Oncology. 37: 11-11. DOI: 10.1200/Jco.2019.37.7_Suppl.11  0.377
2019 Butler S, Muralidhar V, D'Amico AV, Nguyen PL, Rebbeck T, Mahal BAV. Active surveillance and watchful waiting for low-risk prostate cancer in black patients: A population-based analysis. Journal of Clinical Oncology. 37: 10-10. DOI: 10.1200/Jco.2019.37.7_Suppl.10  0.352
2019 Fadelu T, Damuse R, Pecan L, Dubuisson C, Greenberg L, Danjoue S, Lormil JK, Rebbeck T, Shulman LN. Patient characteristics, treatment received, and outcomes of non-metastatic breast cancer patients in Haiti: Report from retrospective cohort. Journal of Clinical Oncology. 37: e18196-e18196. DOI: 10.1200/Jco.2019.37.15_Suppl.E18196  0.342
2019 Leo P, Janowczyk A, Elliott R, Janaki N, Shiradkar R, Farrè X, Yamoah K, Rebbeck T, Shih N, Khani F, Robinson BD, Eklund L, Ettala O, Taimen P, Bostrom P, et al. Computerized histomorphometric features of glandular architecture predict risk of biochemical recurrence following radical prostatectomy: A multisite study. Journal of Clinical Oncology. 37: 5060-5060. DOI: 10.1200/Jco.2019.37.15_Suppl.5060  0.331
2019 Lachance J, Harlemon M, Kachambwa P, Ajayi O, Kim M, Adams M, Pugh E, Peterson L, Rebbeck T. Abstract 2410: Development of a custom genotyping platform and genetic prediction of prostate cancer risks in sub-Saharan Africa Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-2410  0.402
2018 Zhao H, Mitra N, Kanetsky PA, Nathanson KL, Rebbeck TR. A practical approach to adjusting for population stratification in genome-wide association studies: principal components and propensity scores (PCAPS). Statistical Applications in Genetics and Molecular Biology. PMID 30507552 DOI: 10.1515/Sagmb-2017-0054  0.552
2018 O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, ... ... Rebbeck TR, et al. Identification of nine new susceptibility loci for endometrial cancer. Nature Communications. 9: 3166. PMID 30093612 DOI: 10.1038/S41467-018-05427-7  0.321
2018 Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R, Rebbeck T, Jeng CJ, Pyle D, Quinn M, Trimble E, Naik R, Lai CH, Ochiai K, Denny L, et al. Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities. Gynecologic Oncology Reports. 25: 65-69. PMID 29928684 DOI: 10.1016/J.Gore.2018.05.005  0.321
2018 Zhang L, Shin VY, Chai X, Zhang A, Chan TL, Ma ES, Rebbeck TR, Chen J, Kwong A. Breast and ovarian cancer penetrance of mutations among Hong Kong women. Oncotarget. 9: 25025-25033. PMID 29861850 DOI: 10.18632/oncotarget.24382  0.316
2018 Fadelu T, Damuse R, Pecan L, Greenberg L, Danjoue S, Lormil J, Rebbeck T, Shulman L. Association Between Living in Urban Areas and Obesity in Haitian Breast Cancer Patients Journal of Global Oncology. 4. DOI: 10.1200/Jgo.18.25600  0.35
2018 Lu-Yao GL, E J, Lin Y, Rebbeck T, Lu S, Kelly WK, D'Amico AV, Stein MN, Zhang L, Kim I, Demissie K, Ferrari AC, Tan X. Individual and joint effect of postdiagnostic metformin and statin use on prostate cancer mortality among patients with high-risk prostate cancer. Journal of Clinical Oncology. 36: 202-202. DOI: 10.1200/Jco.2018.36.6_Suppl.202  0.379
2018 Lu-Yao GL, Nightingale G, Nikita N, Patel SA, Gandhi K, Leiby B, Hegarty S, Barsevick AM, Padron N, Rebbeck T, Chapman AE, Gomella LG, Kelly WK. Clinical outcomes following androgen receptor axis therapies (ARAT) among men with prostate cancer (PCa) having major cardiovascular diseases (CVDs) or extreme polypharmacy (EPP): A population based study. Journal of Clinical Oncology. 36: 5056-5056. DOI: 10.1200/Jco.2018.36.15_Suppl.5056  0.348
2018 Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Yamoah K, Rebbeck T, Feldman MD, Lal P, Madabhushi A. Computer-extracted stromal features of African-Americans versus Caucasians from H&E slides and impact on prognosis of biochemical recurrence. Journal of Clinical Oncology. 36: 12075-12075. DOI: 10.1200/Jco.2018.36.15_Suppl.12075  0.329
2017 Randall TC, Chuang L, Orang'o E, Rosen B, Uwinkindi F, Rebbeck T, Trimble EL. Strengthening care and research for women's cancers in Sub-Saharan Africa. Gynecologic Oncology Reports. 21: 109-113. PMID 28819635 DOI: 10.1016/J.Gore.2017.06.002  0.323
2017 Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, ... ... Rebbeck TR, et al. Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstetrics and Gynecology. PMID 28486362 DOI: 10.1097/Aog.0000000000002057  0.306
2017 Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... ... Rebbeck TR, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935  0.357
2017 Lynch SM, Mitra N, Ravichandran K, Mitchell J, Spangler E, Zhou W, Paskett ED, Gehlert S, DeGraffinreid C, Stowe R, Dubowitz T, Riethman H, Branas CC, Peek MK, Rebbeck TR. Telomere Length and Neighborhood Circumstances: Evaluating Biological Response to Unfavorable Exposures. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 553-560. PMID 28373169 DOI: 10.1158/1055-9965.Epi-16-0554  0.434
2017 Lynch SM, Mitra N, Ross M, Newcomb C, Dailey K, Jackson T, Zeigler-Johnson CM, Riethman H, Branas CC, Rebbeck TR. A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness. Plos One. 12: e0174548. PMID 28346484 DOI: 10.1371/Journal.Pone.0174548  0.479
2017 Rebbeck TR. Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. Seminars in Radiation Oncology. 27: 3-10. PMID 27986209 DOI: 10.1016/j.semradonc.2016.08.002  0.31
2017 Narayan V, Lal P, Zeigler-Johnson C, Malkowicz SB, Rebbeck T. EZH2 expression and clinical outcome in African-American men with prostate cancer. Journal of Clinical Oncology. 35: 81-81. DOI: 10.1200/Jco.2017.35.6_Suppl.81  0.409
2017 Cullen J, Kuo H, Chen Y, Hurwitz L, Rosner IL, Porter C, Brand TC, Sterbis J, Stroup S, Rebbeck T, D'Amico AV, Lu-Yao GL. Prostate cancer outcomes for African American and caucasian patients undergoing radical prostatectomy. Journal of Clinical Oncology. 35: 40-40. DOI: 10.1200/Jco.2017.35.6_Suppl.40  0.368
2017 Cullen J, Kuo H, Hurwitz L, Rosner IL, Rebbeck T, D'Amico AV, Lu-Yao GL. Predictors of post-surgical race-specific prostate cancer progression. Journal of Clinical Oncology. 35: 5048-5048. DOI: 10.1200/Jco.2017.35.15_Suppl.5048  0.367
2017 Lachance J, Berens A, Hansen M, Teng A, Tishkoff S, Rebbeck T. Abstract A33: Population and evolutionary genomics of prostate cancer-associated variants: implications for health disparities in men of African descent Cancer Research. 77. DOI: 10.1158/1538-7445.Newfront17-A33  0.445
2017 Patel V, Busch E, Cronin A, Pomerantz M, Freedman M, D'Amico A, Rebbeck T. Germline BRCA2 Mutations in Men With Prostate Cancer Assort into Functional Cluster Regions International Journal of Radiation Oncology*Biology*Physics. 99: S32. DOI: 10.1016/J.Ijrobp.2017.06.087  0.348
2016 Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, ... ... Rebbeck TR, et al. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. Human Molecular Genetics. 25: 4835-4846. PMID 28171663 DOI: 10.1093/Hmg/Ddw305  0.322
2016 Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P, Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS, et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Research : Bcr. 18: 112. PMID 27836010 DOI: 10.1186/S13058-016-0768-3  0.397
2016 Hamdi Y, Soucy P, Kuchenbaeker KB, Pastinen T, Droit A, Lemaçon A, Adlard J, Aittomäki K, Andrulis IL, Arason A, Arnold N, Arun BK, Azzollini J, Bane A, Barjhoux L, ... ... Rebbeck T, et al. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Research and Treatment. PMID 27796716 DOI: 10.1007/S10549-016-4018-2  0.451
2016 Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, ... ... Rebbeck TR, et al. Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer. Human Molecular Genetics. PMID 27594435 DOI: 10.1093/hmg/ddw305  0.324
2016 Chen MM, O'Mara TA, Thompson DJ, Painter JN, Attia J, Black A, Brinton L, Chanock S, Chen C, Cheng TH, Cook LS, Crous-Bou M, Doherty J, Friedenreich CM, ... ... Rebbeck TR, et al. GWAS meta-analysis of 16,852 women identifies new susceptibility locus for endometrial cancer. Human Molecular Genetics. PMID 27008869 DOI: 10.1093/Hmg/Ddw092  0.31
2016 Lynch SM, Peek MK, Mitra N, Ravichandran K, Branas C, Spangler E, Zhou W, Paskett ED, Gehlert S, DeGraffinreid C, Rebbeck TR, Riethman H. Race, Ethnicity, Psychosocial Factors, and Telomere Length in a Multicenter Setting. Plos One. 11: e0146723. PMID 26752285 DOI: 10.1371/Journal.Pone.0146723  0.422
2016 Scales R, Spangler E, Morales K, Glanz K, Rebbeck T, Zeigler-Johnson C. Abstract A71: Modification of obesity associations with prostate cancer grade by area-level factors Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-A71  0.358
2016 Lynch S, Mitra N, Ross M, Newcomb C, Daily K, Jackson T, Zeigler-Johnson C, Riethman H, Branas C, Rebbeck T. Abstract 4351: A neighborhood-wide association study (NWAS) in prostate cancer: A new methodologic approach Cancer Research. 76: 4351-4351. DOI: 10.1158/1538-7445.Am2016-4351  0.572
2015 Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, ... ... Rebbeck T, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 28: 529-40. PMID 26461095 DOI: 10.1016/J.Ccell.2015.09.006  0.335
2015 Nan H, Dorgan JF, Rebbeck TR. Genetic variants in hypothalamic-pituitary-adrenal axis genes and breast cancer risk in Caucasians and African Americans. International Journal of Molecular Epidemiology and Genetics. 6: 33-40. PMID 26417403  0.353
2015 Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Cancer Incidence following Expansion of HIV Treatment in Botswana. Plos One. 10: e0135602. PMID 26267867 DOI: 10.1371/Journal.Pone.0135602  0.325
2015 Chai X, Domchek S, Kauff N, Rebbeck T, Chen J. RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. Journal of the National Cancer Institute. 107. PMID 26264690 DOI: 10.1093/Jnci/Djv033  0.411
2015 Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Rebbeck TR, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034  0.316
2015 Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985  0.5
2015 Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, ... ... Rebbeck TR, et al. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1121-9. PMID 25837820 DOI: 10.1158/1055-9965.Epi-14-0317  0.315
2015 Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, Librado P, Sánchez-Gracia A, Rozas J, Bonifaci N, McGuffog L, Pankratz VS, Islam A, Mateo F, Berenguer A, ... ... Rebbeck TR, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. Plos One. 10: e0120020. PMID 25830658 DOI: 10.1371/Journal.Pone.0120020  0.318
2015 Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, ... ... Rebbeck TR, et al. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Human Genetics. 134: 439-50. PMID 25715684 DOI: 10.1007/S00439-015-1534-9  0.308
2015 Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Rebbeck TR, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185  0.32
2015 Lee G, Singanamalli A, Wang H, Feldman MD, Master SR, Shih NN, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Supervised multi-view canonical correlation analysis (sMVCCA): integrating histologic and proteomic features for predicting recurrent prostate cancer. Ieee Transactions On Medical Imaging. 34: 284-97. PMID 25203987 DOI: 10.1109/Tmi.2014.2355175  0.314
2015 Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, ... ... Rebbeck TR, et al. Generalizability of established prostate cancer risk variants in men of African ancestry. International Journal of Cancer. Journal International Du Cancer. 136: 1210-7. PMID 25044450 DOI: 10.1002/Ijc.29066  0.354
2015 Zeigler-Johnson CM, Morales K, Mitchell J, Spangler E, Glanz K, Rebbeck T. Abstract 3722: Modification of obesity effects on prostate cancer outcomes by age and education Cancer Research. 75: 3722-3722. DOI: 10.1158/1538-7445.Am2015-3722  0.377
2015 Spangler E, Zeigler-Johnson C, Mitchell J, Rebbeck T. Abstract 3720: Diabetes and prostate cancer (CaP): Clinical characteristics and disparity in outcomes Cancer Research. 75: 3720-3720. DOI: 10.1158/1538-7445.Am2015-3720  0.356
2015 Yamoah K, Johnson M, Choeurng V, Yousefi K, Haddad Z, Den R, Lal P, Feldman M, Dicker A, Klein E, Davicioni E, Rebbeck T, Schaeffer E. MP6-03 A NOVEL BIOMARKER SIGNATURE WHICH MAY PREDICT AGGRESSIVE DISEASE IN AFRICAN-AMERICAN MEN WITH PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.250  0.362
2014 Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, ... ... Rebbeck TR, et al. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 16: 3416. PMID 25919761 DOI: 10.1186/S13058-014-0492-9  0.304
2014 Nan H, Dorgan JF, Rebbeck TR. Genetic variants in anti-Mullerian hormone and anti-Mullerian hormone receptor genes and breast cancer risk in Caucasians and African Americans. International Journal of Molecular Epidemiology and Genetics. 5: 145-51. PMID 25379134  0.341
2014 Lee G, Sparks R, Ali S, Shih NN, Feldman MD, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients. Plos One. 9: e97954. PMID 24875018 DOI: 10.1371/Journal.Pone.0097954  0.391
2014 Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, ... ... Rebbeck TR, et al. Exome-wide association study of endometrial cancer in a multiethnic population. Plos One. 9: e97045. PMID 24810602 DOI: 10.1371/Journal.Pone.0097045  0.323
2014 Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, Díez O, Ramón Y Cajal T, Konstantopoulou I, Martínez-Bouzas C, Andrés Conejero R, ... ... Rebbeck TR, et al. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. Plos Genetics. 10: e1004256. PMID 24698998 DOI: 10.1371/Journal.Pgen.1004256  0.338
2014 Margolis DJ, Gupta J, Apter AJ, Hoffstad O, Papadopoulos M, Rebbeck TR, Wubbenhorst B, Mitra N. Exome sequencing of filaggrin and related genes in African-American children with atopic dermatitis. The Journal of Investigative Dermatology. 134: 2272-4. PMID 24608987 DOI: 10.1038/Jid.2014.126  0.361
2014 Margolis DJ, Gupta J, Apter AJ, Ganguly T, Hoffstad O, Papadopoulos M, Rebbeck TR, Mitra N. Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. The Journal of Allergy and Clinical Immunology. 133: 784-9. PMID 24184149 DOI: 10.1016/J.Jaci.2013.09.015  0.39
2013 Gabriel CA, Mitra N, Demichele A, Rebbeck T. Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women. Breast Cancer Research and Treatment. 139: 833-43. PMID 23764995 DOI: 10.1007/S10549-013-2592-0  0.587
2013 Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Rebbeck TR, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212  0.34
2013 Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Rebbeck TR, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566  0.303
2013 Zeigler-Johnson C, Morales KH, Spangler E, Chang BL, Rebbeck TR. Relationship of early-onset baldness to prostate cancer in African-American men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 589-96. PMID 23532004 DOI: 10.1158/1055-9965.EPI-12-0944  0.305
2013 Zheng Y, Ogundiran TO, Falusi AG, Nathanson KL, John EM, Hennis AJ, Ambs S, Domchek SM, Rebbeck TR, Simon MS, Nemesure B, Wu SY, Leske MC, Odetunde A, Niu Q, et al. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis. 34: 1520-8. PMID 23475944 DOI: 10.1093/Carcin/Bgt090  0.337
2013 Suneja G, Dryden-Peterson S, Boyer M, Musimar Z, Nsingo-Bvochora M, Ramogola-Masire D, Medhin H, Bekelman J, Lockman S, Rebbeck T. Cancer in Botswana: A Prospective Cohort Study of Cancer Type, Treatment, and Outcomes International Journal of Radiation Oncology*Biology*Physics. 87: S492-S493. DOI: 10.1016/J.Ijrobp.2013.06.1302  0.367
2012 Zhao H, Rebbeck TR, Mitra N. Analyzing genetic association studies with an extended propensity score approach. Statistical Applications in Genetics and Molecular Biology. 11. PMID 23104843 DOI: 10.1515/1544-6115.1790  0.557
2012 Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR. Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men. Prostate Cancer. 2012: 798634. PMID 23091730 DOI: 10.1155/2012/798634  0.325
2012 Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Greene MH, Andrulis IL, Thomassen M, Caligo M, Nathanson KL, Jakubowska A, Osorio A, Hamann U, Godwin AK, Stoppa-Lyonnet D, ... ... Rebbeck TR, et al. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Research and Treatment. 136: 295-302. PMID 23011509 DOI: 10.1007/S10549-012-2255-6  0.33
2012 Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Rebbeck TR, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229  0.329
2012 Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H, ... ... Rebbeck T, et al. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. British Journal of Cancer. 106: 2016-24. PMID 22669161 DOI: 10.1038/Bjc.2012.160  0.414
2012 Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, Shoretz R, Singer CF, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, ... ... Rebbeck TR, et al. Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1321-8. PMID 22430266 DOI: 10.1200/Jco.2011.37.8133  0.327
2012 Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, et al. Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis. 33: 835-40. PMID 22357627 DOI: 10.1093/Carcin/Bgs093  0.307
2012 Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, ... ... Rebbeck TR, et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 645-57. PMID 22351618 DOI: 10.1158/1055-9965.Epi-11-0888  0.326
2012 Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, ... ... Rebbeck T, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R33. PMID 22348646 DOI: 10.1186/Bcr3121  0.395
2012 Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, ... ... Rebbeck TR, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human Mutation. 33: 690-702. PMID 22253144 DOI: 10.1002/Humu.22025  0.339
2012 Hou N, Zheng Y, Gamazon ER, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, et al. Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 552-6. PMID 22237986 DOI: 10.1158/1055-9965.Epi-11-0979  0.334
2012 Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, Zhang J, et al. Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Research and Treatment. 132: 341-5. PMID 22134622 DOI: 10.1007/S10549-011-1890-7  0.325
2012 Sepe DM, McWilliams T, Chen J, Kershenbaum A, Zhao H, La M, Devidas M, Lange B, Rebbeck TR, Aplenc R. Germline genetic variation and treatment response on CCG-1891. Pediatric Blood & Cancer. 58: 695-700. PMID 21618417 DOI: 10.1182/Blood.V116.21.2711.2711  0.592
2012 Margolis DJ, Mitra N, Sandilands A, McLean I, Rebbeck T. Filaggrin mutations: Prognosis and response to therapy overtime Journal of Investigative Dermatology. 132. DOI: 10.1038/Jid.2012.82  0.442
2011 Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, ... ... Rebbeck T, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 13: R110. PMID 22053997 DOI: 10.1186/Bcr3052  0.402
2011 Healey CS, Ahmed S, O'Mara TA, Ferguson K, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F, Howarth K, Gorman M, Hodgson S, ... ... Rebbeck TR, et al. Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Carcinogenesis. 32: 1862-6. PMID 21965274 DOI: 10.1093/Carcin/Bgr214  0.344
2011 Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, ... ... Rebbeck TR, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 20: 4732-47. PMID 21890493 DOI: 10.1093/Hmg/Ddr388  0.316
2011 Chen F, Chen GK, Millikan RC, John EM, Ambrosone CB, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Deming SL, Bandera EV, Nyante S, Palmer JR, Rebbeck TR, Ingles SA, et al. Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Human Molecular Genetics. 20: 4491-503. PMID 21852243 DOI: 10.1093/Hmg/Ddr367  0.318
2011 Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, et al. Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Research. 71: 5792-805. PMID 21799032 DOI: 10.1158/0008-5472.Can-11-0773  0.528
2011 Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, ... ... Rebbeck TR, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32: 1361-5. PMID 21705483 DOI: 10.1093/Carcin/Bgr119  0.322
2011 Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nature Genetics. 43: 570-3. PMID 21602798 DOI: 10.1038/Ng.839  0.335
2011 Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, ... ... Rebbeck T, et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 20: 3304-21. PMID 21593217 DOI: 10.1093/Hmg/Ddr226  0.435
2011 Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, et al. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Research. 71: 3442-6. PMID 21558387 DOI: 10.1158/0008-5472.Can-11-0314  0.305
2011 Margolis DJ, Papadopoulos M, Apter AJ, McLean WH, Mitra N, Rebbeck TR. Obtaining DNA in the mail from a national sample of children with a chronic non-fatal illness. The Journal of Investigative Dermatology. 131: 1765-7. PMID 21509047 DOI: 10.1038/Jid.2011.102  0.403
2011 Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck TR. Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1146-55. PMID 21493872 DOI: 10.1158/1055-9965.Epi-10-0996  0.302
2011 Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson KL, Domchek SM, Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst FB, Verhoef S, van Dooren MF, Jager A, et al. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. British Journal of Cancer. 104: 1356-61. PMID 21427728 DOI: 10.1038/Bjc.2011.91  0.339
2011 Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. Plos One. 6: e16756. PMID 21347432 DOI: 10.1371/Journal.Pone.0016756  0.302
2011 Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, Ostrander EA, Chanock S, Wang MH, Mittal RD, Isaacs WB, Platz EA, Hayes RB. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1075-81. PMID 21343373 DOI: 10.1158/1078-0432.Ccr-10-0881  0.33
2011 Mao JJ, Su HI, Feng R, Donelson ML, Aplenc R, Rebbeck TR, Stanczyk F, DeMichele A. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Research : Bcr. 13: R8. PMID 21251330 DOI: 10.1186/Bcr2813  0.53
2011 O'Mara TA, Fahey P, Ferguson K, Marquart L, Lambrechts D, Despierre E, Vergote I, Amant F, Hall P, Liu J, Czene K, Rebbeck TR, et al. Progesterone receptor gene variants and risk of endometrial cancer. Carcinogenesis. 32: 331-5. PMID 21148628 DOI: 10.1093/carcin/bgq263  0.324
2011 Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck T. Abstract 2740: Decision tree-based modeling of androgen pathway genes and prostate cancer risk Cancer Research. 71: 2740-2740. DOI: 10.1158/1538-7445.Am2011-2740  0.433
2011 Lynch S, Tenhave T, Spangler E, Walker A, Zeigler-Johnson C, Rebbeck T. Abstract 1896: Simple mediation analysis to determine if MSMB is a prostate specific antigen (PSA) or prostate cancer (PC) gene Cancer Research. 71: 1896-1896. DOI: 10.1158/1538-7445.Am2011-1896  0.424
2010 Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research. 70: 9742-54. PMID 21118973 DOI: 10.1158/0008-5472.Can-10-1907  0.336
2010 Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, Beesley J, Healey S, Chen X, Stoppa-Lyonnet D, Tirapo C, Giraud S, Mazoyer S, Muller D, ... ... Rebbeck T, et al. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 12: R102. PMID 21114847 DOI: 10.1186/Bcr2785  0.387
2010 Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Rebbeck T, et al. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. Plos Genetics. 6: e1001183. PMID 21060860 DOI: 10.1371/Journal.Pgen.1001183  0.453
2010 Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans DG, Eeles R, Paterson J, Brewer C, ... ... Rebbeck TR, et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2859-68. PMID 20978178 DOI: 10.1158/1055-9965.Epi-10-0517  0.346
2010 Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, ... ... Rebbeck T, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics. 42: 885-92. PMID 20852631 DOI: 10.1038/Ng.669  0.433
2010 Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, Aplenc R, Vaughan WP, Tallman MS, Rebbeck TR, DeMichele A. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Research : Bcr. 12: R26. PMID 20459744 DOI: 10.1186/Bcr2570  0.509
2010 Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D, Sinilnikova OM, ... ... Rebbeck TR, et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 19: 2886-97. PMID 20418484 DOI: 10.1093/Hmg/Ddq174  0.341
2010 Hirshfield KM, Rebbeck TR, Levine AJ. Germline mutations and polymorphisms in the origins of cancers in women. Journal of Oncology. 2010: 297671. PMID 20111735 DOI: 10.1155/2010/297671  0.305
2010 Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Rebbeck T, et al. Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer Plos Genetics. 6. DOI: 10.1371/Annotation/B28Cf02D-7196-4A16-8B36-6562A0B84F75  0.377
2010 Zeigler‐Johnson CM, Chang B, Panossian S, Spangler E, Malkowicz SB, Rebbeck T. Abstract B122: Multi‐SNP analysis of one‐carbon metabolism genes and prostate cancer outcomes Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B122  0.461
2010 Zeigler-Johnson CM, Liu Z, Spangler E, Rebbeck T. Abstract B69: Effects of obesity and neighborhood socioeconomic status on prostate cancer stage and grade Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-B69  0.372
2009 Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, ... ... Rebbeck TR, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 41: 1116-21. PMID 19767753 DOI: 10.1038/Ng.450  0.303
2009 Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G, Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, et al. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Research. 69: 5801-10. PMID 19584272 DOI: 10.1158/0008-5472.Can-09-0625  0.541
2009 Zhao H, Rebbeck TR, Mitra N. A propensity score approach to correction for bias due to population stratification using genetic and non-genetic factors. Genetic Epidemiology. 33: 679-90. PMID 19353632 DOI: 10.1002/Gepi.20419  0.547
2009 Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers Journal of the National Cancer Institute. 101: 80-87. PMID 19141781 DOI: 10.1093/jnci/djn442  0.31
2009 Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL, Lacey JV, Le Marchand L, ... ... Rebbeck TR, et al. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 242-7. PMID 19124504 DOI: 10.1158/1055-9965.Epi-08-0689  0.327
2008 Tan YC, Zeigler-Johnson C, Mittal RD, Mandhani A, Mital B, Rebbeck TR, Rennert H. Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2431-5. PMID 18768513 DOI: 10.1158/1055-9965.EPI-07-2823  0.311
2008 DeMichele A, Troxel AB, Berlin JA, Weber AL, Bunin GR, Turzo E, Schinnar R, Burgh D, Berlin M, Rubin SC, Rebbeck TR, Strom BL. Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4151-9. PMID 18757329 DOI: 10.1200/Jco.2007.14.0921  0.307
2008 Wei Z, Li M, Rebbeck T, Li H. U-statistics-based tests for multiple genes in genetic association studies. Annals of Human Genetics. 72: 821-33. PMID 18691161 DOI: 10.1111/J.1469-1809.2008.00473.X  0.353
2008 Apter AJ, Schelleman H, Walker A, Addya K, Rebbeck T. Clinical and genetic risk factors of self-reported penicillin allergy Journal of Allergy and Clinical Immunology. 122: 152-158. PMID 18538381 DOI: 10.1016/J.Jaci.2008.03.037  0.34
2008 Rennert H, Zeigler-Johnson C, Mittal RD, Tan YC, Sadowl CM, Edwards J, Finley MJ, Mandhani A, Mital B, Rebbeck TR. Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer. Urology. 72: 456-60. PMID 18436282 DOI: 10.1016/j.urology.2007.11.139  0.3
2008 Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, ... ... Rebbeck TR, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. American Journal of Human Genetics. 82: 937-48. PMID 18355772 DOI: 10.1016/J.Ajhg.2008.02.008  0.332
2007 DeMichele A, Gimotty P, Botbyl J, Aplenc R, Colligon T, Foulkes AS, Rebbeck TR. In response to "Drug metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5675-7. PMID 18065748 DOI: 10.1200/Jco.2006.10.1485  0.461
2007 Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, ... ... Rebbeck TR, et al. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1416-21. PMID 17627006 DOI: 10.1158/1055-9965.EPI-07-0129  0.319
2007 Rebbeck TR, Troxel AB, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Berlin M, Schinnar R, Berlin JA, Strom BL. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 444-50. PMID 17372239 DOI: 10.1158/1055-9965.Epi-06-0800  0.313
2007 Domchek SM, Rebbeck TR. Prophylactic oophorectomy in women at increased cancer risk Current Opinion in Obstetrics and Gynecology. 19: 27-30. PMID 17218848 DOI: 10.1097/GCO.0b013e32801195da  0.303
2007 Rebbeck TR, Troxel AB, Norman S, Bunin GR, DeMichele A, Baumgarten M, Berlin M, Schinnar R, Strom BL. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. International Journal of Cancer. Journal International Du Cancer. 120: 1523-8. PMID 17205521 DOI: 10.1002/Ijc.22485  0.303
2007 Gor PP, Gray RJ, Horn M, Rebbeck TR, Gimotty PA, Aplenc R, Pins M, Tallman MS, DeMichele A. Association of polymorphic drug metabolizing enzymes (DME) with outcomes in breast cancer patients treated on the ECOG 2190/Intergroup 0121 (E2190/Int0121) study Journal of Clinical Oncology. 25: 596-596. DOI: 10.1200/Jco.2007.25.18_Suppl.596  0.485
2006 Rebbeck TR, Troxel AB, Wang Y, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Bunin G, DeMichele A, Rubin SC, Baumgarten M, Berlin M, Schinnar R, Berlin JA, et al. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Journal of the National Cancer Institute. 98: 1311-20. PMID 16985250 DOI: 10.1093/Jnci/Djj360  0.486
2006 Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in epidemiologic studies of gene-gene or gene-environment interactions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 124-32. PMID 16434597 DOI: 10.1158/1055-9965.Epi-05-0304  0.406
2006 Kauff ND, Domchek SM, Friebel TM, Lee JB, Roth R, Robson ME, Barakat RR, Norton L, Offit K, Rebbeck TR. Multi-center prospective analysis of risk-reducing salpingo-oophorectomy to prevent BRCA-associated breast and ovarian cancer Journal of Clinical Oncology. 24: 1003-1003. DOI: 10.1200/jco.2006.24.18_suppl.1003  0.34
2006 Andreadis C, Gimotty P, Hammond R, Wahl P, Houldsworth J, Schuster S, Rebbeck T. Expression Levels of Glutathione Peroxidase 1 (GPx1) and Multi-Drug Resistance 1 (MDR1; ABCB1) Identify Patients with Diffuse Large B-Cell Lymphoma (DLBCL) That Have Superior Clinical Outcomes. Blood. 108: 839-839. DOI: 10.1182/Blood.V108.11.839.839  0.332
2005 Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample Journal of the National Cancer Institute. 97: 1507-1515. PMID 16234564 DOI: 10.1093/Jnci/Dji312  0.44
2005 Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7491-6. PMID 16234515 DOI: 10.1200/Jco.2004.00.7138  0.383
2005 DeMichele A, Aplenc R, Botbyl J, Colligan T, Wray L, Klein-Cabral M, Foulkes A, Gimotty P, Glick J, Weber B, Stadtmauer E, Rebbeck TR. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5552-9. PMID 16110016 DOI: 10.1200/Jco.2005.06.208  0.503
2005 Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. Journal of the National Cancer Institute. 97: 998-1007. PMID 15998953 DOI: 10.1093/Jnci/Dji176  0.348
2005 Wang Y, Localio R, Rebbeck TR. Bias correction with a single null marker for population stratification in candidate gene association studies. Human Heredity. 59: 165-75. PMID 15920341 DOI: 10.1159/000085940  0.382
2005 Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Research. 65: 2482-7. PMID 15781665 DOI: 10.1158/0008-5472.Can-04-2606  0.633
2005 Demichele A, Troxel A, Weber A, Berlin J, Bunin G, Turzo E, Burgh D, Schinnar R, Rubin S, Rebbeck T, Strom B. Effect of raloxifene on endometrial cancer risk in a population-based, case-control study Journal of Clinical Oncology. 23: 5001-5001. DOI: 10.1200/Jco.2005.23.16_Suppl.5001  0.427
2004 Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, Patacsil M, Aplenc R, Wein AJ, Malkowicz SB, Rebbeck TR. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Research. 64: 8461-7. PMID 15548719 DOI: 10.1158/0008-5472.Can-04-1651  0.605
2004 Huang J, Domchek SM, Brose MS, Rebbeck TR, Nathanson KL, Weber BL. Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers Journal of Medical Genetics. 41. PMID 15520402 DOI: 10.1136/Jmg.2004.022913  0.304
2004 Vogl FD, Taioli E, Maugard C, Zheng W, Ribeiro Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P, Boffetta P. Glutathione S-transferases M1, T1, and P1 and breast cancer: A pooled analysis Cancer Epidemiology Biomarkers and Prevention. 13: 1473-1479. PMID 15342448  0.321
2004 Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in case-control association studies of admixed populations. Genetic Epidemiology. 27: 14-20. PMID 15185399 DOI: 10.1002/Gepi.20003  0.423
2003 Aplenc R, Glatfelter W, Han P, Rappaport E, La M, Cnaan A, Blackwood MA, Lange B, Rebbeck T. CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 122: 240-4. PMID 12846892 DOI: 10.1046/J.1365-2141.2003.04430.X  0.555
2003 Aplenc R, Zhao H, Rebbeck TR, Propert KJ. Group sequential methods and sample size savings in biomarker-disease association studies. Genetics. 163: 1215-9. PMID 12663557  0.591
2002 Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BCRA1 mutation carriers identified in a risk evaluation program Journal of the National Cancer Institute. 94: 1365-1372. PMID 12237282 DOI: 10.1093/Jnci/94.18.1365  0.326
2002 Aplenc R, Orudjev E, Swoyer J, Manke B, Rebbeck T. Differential bone marrow aspirate DNA yields from commercial extraction kits. Leukemia. 16: 1865-6. PMID 12200706 DOI: 10.1038/Sj.Leu.2402681  0.412
2002 Rebbeck TR. Inherited predisposition and breast cancer: Modifiers of BRCA1/2-associated breast cancer risk Environmental and Molecular Mutagenesis. 39: 228-234. PMID 11921193 DOI: 10.1002/em.10050  0.326
2001 Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, ... ... Rebbeck T, et al. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 11: 635-8. PMID 11668223 DOI: 10.1097/00008571-200110000-00010  0.436
2001 Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet JS, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Research. 61: 5420-4. PMID 11454686  0.499
2001 Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, Rebbeck TR, Sidransky D, Gazdar AF, El-Deiry WS. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 1688-97. PMID 11410508  0.479
2001 Nathanson KL, Omaruddin R, Malkowicz SB, Rebbeck TR. An intronic variant in PTEN is not associated with prostate cancer risk Cancer Epidemiology Biomarkers and Prevention. 10: 277-278. PMID 11303600  0.307
2000 Friedman D, Thompson S, Yasui Y, Bunin G, Rebbeck T, Nichols K, Potter J, Meadows A. Genetic risk factors for second malignancy Journal of Pediatric Hematology/Oncology. 22: 368. DOI: 10.1097/00043426-200007000-00028  0.303
1999 Carroll BT, Couch FJ, Rebbeck TR, Weber BL. Polymorphisms in PTEN in breast cancer families Journal of Medical Genetics. 36: 94-96. PMID 10051004 DOI: 10.1136/Jmg.36.2.94  0.308
1999 Rebbeck TR. Inherited genetic predisposition in breast cancer: A population-based perspective Cancer. 86: 1673-1681.  0.316
1998 Rebbeck TR, Rogatko A, Viana MAG. Evaluation of genotype data in clinical risk assessment: Methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer Genetic Testing. 1: 157-164. PMID 10464641  0.339
1998 Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. P53 germline polymorphisms are associated with an increased risk for breast cancer in German women Anticancer Research. 18: 2095-2099. PMID 9677474  0.316
1997 Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility Cancer Epidemiology Biomarkers and Prevention. 6: 733-743. PMID 9298582  0.342
1997 Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. The New England Journal of Medicine. 336: 1409-15. PMID 9145677 DOI: 10.1056/Nejm199705153362002  0.391
1996 Rebbeck TR, Turner ST, Sing CF. Probability of having hypertension: Effects of sex, history of hypertension in parents, and other risk factors Journal of Clinical Epidemiology. 49: 727-734. PMID 8691221 DOI: 10.1016/0895-4356(96)00015-7  0.533
1996 Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genetics. 12: 309-11. PMID 8589723 DOI: 10.1038/Ng0396-309  0.358
1995 Rogatko A, Rebbeck T, Zacks S. Risk prediction with linked markers: Pedigree analysis American Journal of Medical Genetics. 59: 24-32. PMID 8849005 DOI: 10.1002/Ajmg.1320590106  0.333
1993 Rebbeck TR, Turner ST, Sing CF. Sodium-lithium countertransport genotype and the probability of hypertension in adults Hypertension. 22: 560-568. PMID 8406661 DOI: 10.1161/01.Hyp.22.4.560  0.537
1992 Turner ST, Rebbeck TR, Sing CF. Sodium-lithium countertransport and probability of hypertension in caucasians 47 to 89 years old Hypertension. 20: 841-850. PMID 1452301  0.529
Low-probability matches (unlikely to be authored by this person)
1998 Walker AH, Jaffe JM, Gunasegaram S, Cummings SA, Huang CS, Chern HD, Olopade OI, Weber BL, Rebbeck TR. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online. Human Mutation. 12: 289. PMID 10660343  0.3
2017 Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, ... ... Rebbeck TR, et al. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28377418 DOI: 10.1158/1055-9965.Epi-16-0567  0.3
2006 Domchek SM, Stopfer JE, Rebbeck TR. Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers Jnccn Journal of the National Comprehensive Cancer Network. 4: 177-182. PMID 16451773  0.3
2012 Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 53-60. PMID 22144497 DOI: 10.1158/1055-9965.EPI-11-0727  0.299
2007 Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, ... ... Rebbeck TR, et al. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers Clinical Breast Cancer. 7: 875-882. DOI: 10.3816/CBC.2007.n.053  0.298
2009 Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, et al. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Research : Bcr. 11: R76. PMID 19843326 DOI: 10.1186/Bcr2414  0.298
2014 De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N, Attia J, Black A, Brinton L, Chen C, Chen C, Cook LS, Crous-Bou M, Doherty J, Dunning AM, ... ... Rebbeck TR, et al. Genome-wide association study of endometrial cancer in E2C2. Human Genetics. 133: 211-24. PMID 24096698 DOI: 10.1007/S00439-013-1369-1  0.297
2010 Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E, Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S, Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, ... ... Rebbeck TR, et al. Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers Breast Cancer Research and Treatment. 124: 195-203. PMID 20180014 DOI: 10.1007/S10549-010-0799-X  0.297
2004 Rebbeck TR. Biomarkers of inherited susceptibility and cancer Iarc Scientific Publications. 91-103. PMID 15055292  0.296
2011 Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H, ... ... Rebbeck TR, et al. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1032-8. PMID 21393566 DOI: 10.1158/1055-9965.Epi-10-0909  0.296
2022 Awasthi S, Mahal BA, Park JY, Creed JH, Williams VL, Elkenawi A, Meadows SO, Pow-Sang JM, Lu-Yao G, Kelly WK, Lang DY, Zgibor J, Rebbeck TR, Yamoah K. Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysis. Prostate Cancer and Prostatic Diseases. PMID 35194179 DOI: 10.1038/s41391-022-00510-z  0.296
2005 Shatalova EG, Walther SE, Favorova OO, Rebbeck TR, Blanchard RL. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study Breast Cancer Research : Bcr. 7: R909-R921. PMID 16280036  0.295
2018 Lachance J, Berens AJ, Hansen MEB, Teng AK, Tishkoff SA, Rebbeck TR. Genetic hitchhiking and population bottlenecks contribute to prostate cancer disparities in men of African descent. Cancer Research. PMID 29438991 DOI: 10.1158/0008-5472.Can-17-1550  0.293
2007 Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, ... ... Rebbeck TR, et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. American Journal of Human Genetics. 81: 1186-200. PMID 17999359 DOI: 10.1086/522611  0.293
2015 Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, ... ... Rebbeck TR, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 308-16. PMID 25336561 DOI: 10.1158/1055-9965.Epi-14-0532  0.292
2009 Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB, Couch FJ, Pereira LH, Greene MH, Andrulis IL, Pasche B, Kaklamani V, et al. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Research and Treatment. 115: 185-92. PMID 18523885 DOI: 10.1007/S10549-008-0064-8  0.292
2020 Chen J, Bae E, Zhang L, Hughes K, Parmigiani G, Braun D, Rebbeck TR. Penetrance of Breast and Ovarian Cancer in Women Who Carry a Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis. Jnci Cancer Spectrum. 4: pkaa029. PMID 32676552 DOI: 10.1093/jncics/pkaa029  0.292
1997 Rebbeck TR, Walker AH, Phelan CM, Godwin AK, Buetow KH, Garber JE, Narod SA, Weber BL. Defining etiologic heterogeneity in breast cancer using genetic biomarkers. Progress in Clinical and Biological Research. 396: 53-61. PMID 9108589  0.292
2009 Rebbeck TR, DeMichele A, Tran TV, Panossian S, Bunin GR, Troxel AB, Strom BL. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis. 30: 269-74. PMID 19028704 DOI: 10.1093/Carcin/Bgn247  0.291
2006 Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis. 27: 599-605. PMID 16244359 DOI: 10.1093/Carcin/Bgi246  0.29
2011 Zeigler-Johnson CM, Tierney A, Rebbeck TR, Rundle A. Prostate cancer severity associations with neighborhood deprivation. Prostate Cancer. 2011: 846263. PMID 22111000 DOI: 10.1155/2011/846263  0.29
2020 Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Brinton L, Buchanan DD, Chanock SJ, Chen C, Chen MM, Cheng THT, Cook LS, ... ... Rebbeck TR, et al. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. International Journal of Cancer. PMID 32851660 DOI: 10.1002/Ijc.33206  0.29
2000 Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers Clinical Cancer Research. 6: 4259-4264. PMID 11106241  0.289
2004 Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, ... ... Rebbeck T, et al. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. International Journal of Cancer. Journal International Du Cancer. 110: 266-70. PMID 15069692 DOI: 10.1002/Ijc.20114  0.289
2012 Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, ... ... Rebbeck TR, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. American Journal of Epidemiology. 176: 269-78. PMID 22831825 DOI: 10.1093/Aje/Kws129  0.289
2009 Apter AJ, Schelleman H, Rebbeck T. Reply Journal of Allergy and Clinical Immunology. 123: 509-510. DOI: 10.1016/J.Jaci.2008.10.059  0.288
2011 Domchek SM, Friebel T, Neuhausen SL, Lynch HT, Singer CF, Eeles RA, Isaacs C, Tung NM, Ganz PA, Couch FJ, Weitzel JN, Olopade OI, Rubinstein WS, Tomlinson GE, Pichert GC, ... ... Rebbeck TR, et al. Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1501. PMID 28023617 DOI: 10.1200/jco.2011.29.15_suppl.1501  0.288
1999 Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein AJ, Malkowicz SB. Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 8: 283-7. PMID 10207629  0.287
1998 Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, ... ... Rebbeck TR, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. American Journal of Human Genetics. 62: 676-89. PMID 9497246 DOI: 10.1086/301749  0.287
2011 Neuhausen SL, Brummel S, Ding YC, Steele L, Nathanson KL, Domchek S, Rebbeck TR, Singer CF, Pfeiler G, Lynch HT, Garber JE, Couch F, Weitzel JN, Godwin A, Narod SA, et al. Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1690-702. PMID 21708937 DOI: 10.1158/1055-9965.Epi-10-1336  0.287
2011 Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, ... ... Rebbeck TR, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature Genetics. 43: 1210-4. PMID 22037553 DOI: 10.1038/Ng.985  0.287
2015 Blein S, Bardel C, Danjean V, McGuffog L, Healey S, Barrowdale D, Lee A, Dennis J, Kuchenbaecker KB, Soucy P, Terry MB, Chung WK, Goldgar DE, Buys SS, ... ... Rebbeck TR, et al. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 17: 61. PMID 25925750 DOI: 10.1186/S13058-015-0567-2  0.287
2000 Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB. Association of HPC2/ELAC2 genotypes and prostate cancer. American Journal of Human Genetics. 67: 1014-9. PMID 10986046 DOI: 10.1086/303096  0.286
2022 Chen F, Darst BF, Madduri RK, Rodriguez AA, Sheng X, Rentsch CT, Andrews C, Tang W, Kibel AS, Plym A, Cho K, Jalloh M, Gueye SM, Niang L, Ogunbiyi OJ, ... ... Rebbeck TR, et al. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: a meta-analysis within diverse populations. Elife. 11. PMID 35801699 DOI: 10.7554/eLife.78304  0.286
2020 Iyer HS, James P, Valeri L, Hart JE, Pernar CH, Mucci LA, Holmes MD, Laden F, Rebbeck TR. The association between neighborhood greenness and incidence of lethal prostate cancer: A prospective cohort study. Environmental Epidemiology (Philadelphia, Pa.). 4: e091. PMID 32656487 DOI: 10.1097/EE9.0000000000000091  0.286
2006 Ambrosone CB, Rebbeck TR, Morgan GJ, Albain KS, Calle EE, Evans WE, Hayes DF, Kushi LH, McLeod HL, Rowland JH, Ulrich CM. New developments in the epidemiology of cancer prognosis: Traditional and molecular predictors of treatment response and survival Cancer Epidemiology Biomarkers and Prevention. 15: 2042-2046. PMID 17119026 DOI: 10.1158/1055-9965.Epi-06-0827  0.286
1995 Hoskins KF, Stopfer JE, Calzone KA, Weber BL, Merajver SD, Rebbeck TR, Garber JE. Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians Jama: the Journal of the American Medical Association. 273: 577-585. PMID 7837392 DOI: 10.1001/Jama.1995.03520310075033  0.286
2008 Rebbeck TR, Domchek SM. Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 10: 108. PMID 18710587 DOI: 10.1186/bcr2115  0.285
2008 Rebbeck TR, Domchek SM. Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 10: 108. PMID 18710587 DOI: 10.1186/bcr2115  0.285
2002 Rebbeck TR. Inherited genotype and prostate cancer outcomes Cancer Epidemiology Biomarkers and Prevention. 11: 945-952. PMID 12376492  0.284
2010 Domchek SM, Friebel TM, Singer CF, Gareth Evans D, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van T'veer L, Tung N, Weitzel JN, Couch FJ, ... ... Rebbeck TR, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality Jama - Journal of the American Medical Association. 304: 967-975. PMID 20810374 DOI: 10.1001/Jama.2010.1237  0.283
2011 Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gómez-Baldó L, Bogliolo M, Lázaro C, Blanco I, Brunet J, Aguilar H, Fernández-Rodríguez J, Seal S, Renwick A, Rahman N, ... ... Rebbeck TR, et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research : Bcr. 13: R40. PMID 21466675 DOI: 10.1186/Bcr2862  0.283
2017 Rebbeck TR. Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood. Cold Spring Harbor Perspectives in Medicine. PMID 29229666 DOI: 10.1101/cshperspect.a030387  0.283
2023 Rebbeck T, Janivara R, Chen W, Hazra U, Baichoo S, Agalliu I, Kachambwa P, Simonti C, Brown L, Tambe S, Kim M, Harlemon M, Jalloh M, Muzondiwa D, Naidoo D, et al. Heterogeneous genetic architectures and evolutionary genomics of prostate cancer in Sub-Saharan Africa. Research Square. PMID 37886553 DOI: 10.21203/rs.3.rs-3378303/v1  0.282
2013 Butts S, Sammel M, Greer C, Rebbeck T, Freeman E. Anti-mullerian hormone decline in smokers is modified by genetic background in a race-specific fashion: results from a population-based longitudinal study Fertility and Sterility. 100: S9-S10. DOI: 10.1016/J.Fertnstert.2013.07.152  0.282
2011 Giri VN, Ruth K, Hughes L, Uzzo RG, Chen DY, Boorjian SA, Viterbo R, Rebbeck TR. Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val. Bju International. 107: 466-70. PMID 20735386 DOI: 10.1111/j.1464-410X.2010.09522.x  0.282
2002 Rebbeck TR. The contribution of inherited genotype to breast cancer Breast Cancer Research. 4: 85-89. PMID 12052249 DOI: 10.1186/bcr430  0.281
2014 Chai X, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Tung N, Weitzel JN, Couch FJ, Hulick PJ, Ganz PA, ... ... Rebbeck TR, et al. Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 148: 397-406. PMID 25311111 DOI: 10.1007/S10549-014-3134-0  0.281
2015 Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, ... ... Rebbeck TR, et al. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes & Control : Ccc. 26: 287-96. PMID 25534916 DOI: 10.1007/S10552-014-0510-3  0.28
1994 Rebbeck TR, Rosvold EA, Duggan DJ, Zhang J, Buetow KH. Genetics of CYP1A1: Coamplification of Specific Alleles by Polymerase Chain Reaction and Association with Breast Cancer Cancer Epidemiology Biomarkers and Prevention. 3: 511-514. PMID 8000303  0.279
2015 Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal P, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, et al. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26195723 DOI: 10.1200/Jco.2014.59.8912  0.279
2007 Israni AK, Li N, Sidhwani S, Rosas S, Kong X, Joffe M, Rebbeck T, Feldman HI. Association of hypertension genotypes and decline in renal function after kidney transplantation. Transplantation. 84: 1240-7. PMID 18049108 DOI: 10.1097/01.Tp.0000287324.95119.Ae  0.278
2018 Yuan J, Hu Z, Mahal BA, Zhao SD, Kensler KH, Pi J, Hu X, Zhang Y, Wang Y, Jiang J, Li C, Zhong X, Montone KT, Guan G, Tanyi JL, ... ... Rebbeck TR, et al. Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. Cancer Cell. 34: 549-560.e9. PMID 30300578 DOI: 10.1016/J.Ccell.2018.08.019  0.278
2014 Neslund-Dudas C, Levin AM, Beebe-Dimmer JL, Bock CH, Nock NL, Rundle A, Jankowski M, Krajenta R, Dou QP, Mitra B, Tang D, Rebbeck TR, Rybicki BA. Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men. Cancer Causes & Control : Ccc. 25: 869-79. PMID 24801046 DOI: 10.1007/S10552-014-0387-1  0.278
2005 Rebbeck TR. Genetics, disparities, and prostate cancer Ldi Issue Brief. 10: 1-4. PMID 16114130  0.277
2020 Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Fu P, Yamoah K, Khani F, Robinson BD, Rebbeck TR, Feldman M, Lal P, Madabhushi A. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32139401 DOI: 10.1158/1078-0432.Ccr-19-2659  0.276
2014 Friebel TM, Domchek SM, Rebbeck TR. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. Journal of the National Cancer Institute. 106: dju091. PMID 24824314 DOI: 10.1093/jnci/dju091  0.276
2004 Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1055-62. PMID 14981104 DOI: 10.1200/Jco.2004.04.188  0.276
2005 Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, Isaacs C, Olopade OI, Neuhausen SL, van 't Veer L, Eeles R, Evans DG, Tomlinson G, Matloff E, Narod SA, et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7804-10. PMID 16219936 DOI: 10.1200/Jco.2004.00.8151  0.276
1998 Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. Journal of the National Cancer Institute. 90: 761-6. PMID 9605646 DOI: 10.1093/Jnci/90.10.761  0.275
1998 Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. American Journal of Obstetrics and Gynecology. 178: 670-7. PMID 9579428 DOI: 10.1016/S0002-9378(98)70476-4  0.275
2013 Hughes L, Ruth K, Rebbeck TR, Giri VN. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men. Prostate Cancer and Prostatic Diseases. 16: 308-14. PMID 24061634 DOI: 10.1038/pcan.2013.36  0.275
2007 Rebbeck TR, Troxel AB, Shatalova EG, Blanchard R, Norman S, Bunin G, Demichele A, Schinnar R, Berlin JA, Strom BL. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1318-20. PMID 17548708 DOI: 10.1158/1055-9965.Epi-07-0084  0.275
2022 Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, Kawachi I, Campbell PT, Giovannucci EL, Weiderpass E, Rebbeck TR, Ogino S. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nature Reviews. Clinical Oncology. PMID 36068272 DOI: 10.1038/s41571-022-00672-8  0.275
2020 Tegally H, Kensler KH, Mungloo-Dilmohamud Z, Ghoorah AW, Rebbeck TR, Baichoo S. Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles. Plos One. 15: e0242780. PMID 33232371 DOI: 10.1371/journal.pone.0242780  0.274
2023 Bae E, Dias JA, Huang T, Chen J, Parmigiani G, Rebbeck TR, Braun D. Variant-specific Mendelian Risk Prediction Model. Biorxiv : the Preprint Server For Biology. PMID 36945459 DOI: 10.1101/2023.03.06.531363  0.274
2019 Cowan A, Higgins A, Fonseca R, Getz G, Borrello I, Rebbeck T, Murray D, Johnson J, Bustoros M, Stewart C, Zavidij O, Adalsteinsson V, Soule P, Hamilton C, Shayegh N, et al. The PROMISE Study: A Nationwide Project for Predicting the Progression of Developing Myeloma in a High-Risk Screened Population Clinical Lymphoma Myeloma and Leukemia. 19: e310. DOI: 10.1016/J.Clml.2019.09.509  0.273
2012 Braithwaite D, Boffetta P, Rebbeck TR, Meyskens F. Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1606-10. PMID 22850804 DOI: 10.1158/1055-9965.Epi-12-0848  0.273
2005 Spangler E, Zeigler-Johnson CM, Malkowicz SB, Wein AJ, Rebbeck TR. Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors International Journal of Cancer. 113: 471-474. PMID 15455347 DOI: 10.1002/ijc.20578  0.273
2015 Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Correction: Cancer Incidence following Expansion of HIV Treatment in Botswana. Plos One. 10: e0138742. PMID 26376079 DOI: 10.1371/Journal.Pone.0138742  0.273
2010 Domchek SM, Rebbeck TR. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations. Ldi Issue Brief. 16: 1-4. PMID 21545057  0.272
2020 Mahal BA, Alshalalfa M, Kensler KH, Chowdhury-Paulino I, Kantoff P, Mucci LA, Schaeffer EM, Spratt D, Yamoah K, Nguyen PL, Rebbeck TR. Racial Differences in Genomic Profiling of Prostate Cancer. The New England Journal of Medicine. 383: 1083-1085. PMID 32905685 DOI: 10.1056/Nejmc2000069  0.272
2011 Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, ... ... Rebbeck TR, et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 23-32. PMID 21071540 DOI: 10.1158/1055-9965.Epi-10-0698  0.272
2008 Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, ... ... Rebbeck TR, et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1331-7. PMID 18268356 DOI: 10.1200/JCO.2007.13.9626  0.272
2005 Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 949-57. PMID 15824169 DOI: 10.1158/1055-9965.EPI-04-0637  0.272
2023 Shi J, Kraft P, Rosner B, Benavente Y, Black A, Brinton LA, Chen C, Clarke MA, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Frias-Gomez J, Friedenreich CM, Garcia-Closas M, ... ... Rebbeck TR, et al. Risk prediction models for endometrial cancer: development and validation in an international consortium. Journal of the National Cancer Institute. PMID 36688725 DOI: 10.1093/jnci/djad014  0.27
2012 Cohen JV, Chiel L, Boghossian L, Jones M, Stopfer JE, Powers J, Rebbeck TR, Nathanson KL, Domchek SM. Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Familial Cancer. 11: 69-75. PMID 21898151 DOI: 10.1007/S10689-011-9480-8  0.27
2017 Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, et al. Precancer Atlas to Drive Precision Prevention Trials. Cancer Research. 77: 1510-1541. PMID 28373404 DOI: 10.1158/0008-5472.Can-16-2346  0.269
2023 Al-Sukhun S, Masannat Y, Wegman-Ostrosky T, Shrikhande SV, Manirakiza A, Fadelu T, Rebbeck TR. Germline Testing Around the Globe: Challenges in Different Practice Settings. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 43: e390522. PMID 37220318 DOI: 10.1200/EDBK_390522  0.269
2010 Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, et al. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Research and Treatment. 124: 441-51. PMID 20309627 DOI: 10.1007/S10549-010-0842-Y  0.269
2023 Hoffmann TJ, Graff RE, Madduri RK, Rodriguez AA, Cario CL, Feng K, Jiang Y, Wang A, Klein RJ, Pierce BL, Eggener S, Tong L, Blot W, Long J, Rebbeck T, et al. Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction. Medrxiv : the Preprint Server For Health Sciences. PMID 37961155 DOI: 10.1101/2023.10.27.23297676  0.268
2019 Butler S, Muralidhar V, Chavez J, Fullerton Z, Mahal A, Nezolosky M, Vastola M, Zhao SG, D'Amico AV, Dess RT, Feng FY, King MT, Mouw KW, Spratt DE, Trinh QD, ... ... Rebbeck TR, et al. Active Surveillance for Low-Risk Prostate Cancer in Black Patients. The New England Journal of Medicine. 380: 2070-2072. PMID 31116925 DOI: 10.1056/Nejmc1900333  0.268
2000 Eisen A, Rebbeck TR, Wood WC, Weber BL. Prophylactic surgery in women with a hereditary to breast and ovarian cancer Journal of Clinical Oncology. 18: 1980-1995. PMID 10784640 DOI: 10.1200/Jco.2000.18.9.1980  0.268
2015 Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urologic Oncology. 33: 70.e15-22. PMID 25304288 DOI: 10.1016/J.Urolonc.2014.07.005  0.268
2022 Hansen M, Hamieh NM, Markt SC, Vaselkiv JB, Pernar CH, Gonzalez-Feliciano AG, Peisch S, Chowdhury-Paulino IM, Rencsok EM, Rebbeck TR, Platz EA, Giovannucci EL, Wilson KM, Mucci LA. Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening Patterns. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35247879 DOI: 10.1158/1055-9965.EPI-21-1064  0.267
2019 Butler S, Muralidhar V, Nguyen P, Rebbeck T, Mahal B. Conservative Management for Low-Risk Prostate Cancer in Black Patients: A Population-Based Analysis International Journal of Radiation Oncology*Biology*Physics. 105: E268. DOI: 10.1016/j.ijrobp.2019.06.1883  0.267
2015 Banerjee S, Wei Z, Tan F, Peck KN, Shih N, Feldman M, Rebbeck TR, Alwine JC, Robertson ES. Distinct microbiological signatures associated with triple negative breast cancer. Scientific Reports. 5: 15162. PMID 26469225 DOI: 10.1038/Srep15162  0.264
2015 Chan J, Sammel M, Friebel T, Gracia C, Rebbeck T. Tubal ligation does not modify ovarian cancer risk in BRCA mutation carriers Fertility and Sterility. 104: e259. DOI: 10.1016/J.Fertnstert.2015.07.813  0.264
2020 Kensler KH, Rebbeck TR. Cancer Progress and Priorities: Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 29: 267-277. PMID 32024765 DOI: 10.1158/1055-9965.EPI-19-0412  0.264
2020 Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, ... ... Rebbeck TR, et al. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000046. PMID 32516092 DOI: 10.1200/Jco.20.00046  0.264
2007 Malkowicz SB, Zeigler-Johnson C, Spangler E, Panossian S, Wein AJ, Rebbeck TR. 1770: Obesity is Associated with Poorer Clinical Outcomes in Prostate Cancer Patients with high-risk Androgen Receptor Genotypes Journal of Urology. 177: 588-588. DOI: 10.1016/s0022-5347(18)31958-x  0.264
2008 Zeigler-Johnson CM, Spangler E, Jalloh M, Gueye SM, Rennert H, Rebbeck TR. Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes. The Canadian Journal of Urology. 15: 3872-82. PMID 18304397  0.264
2020 Tan XL, E JY, Lin Y, Rebbeck TR, Lu SE, Shang M, Kelly WK, D'Amico A, Stein MN, Zhang L, Jang TL, Kim IY, Demissie K, Ferrari A, Lu-Yao G. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer. Cancer Medicine. PMID 32035002 DOI: 10.1002/Cam4.2862  0.263
2018 Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... ... Rebbeck TR, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132  0.263
2023 Kensler KH, Johnson R, Morley F, Albrair M, Dickerman BA, Gulati R, Holt SK, Iyer HS, Kibel AS, Lee JR, Preston MA, Vassy JL, Wolff EM, Nyame YA, Etzioni R, ... Rebbeck TR, et al. Prostate Cancer Screening in African American Men: A Review of the Evidence. Journal of the National Cancer Institute. PMID 37713266 DOI: 10.1093/jnci/djad193  0.263
2002 Nathanson KL, Shugart YY, Omaruddin R, Szabo C, Goldgar D, Rebbeck TR, Weber BL. CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Human Molecular Genetics. 11: 1327-32. PMID 12019214 DOI: 10.1093/Hmg/11.11.1327  0.262
2002 Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. The New England Journal of Medicine. 346: 1616-22. PMID 12023993 DOI: 10.1056/Nejmoa012158  0.262
2006 Strom BL, Schinnar R, Weber AL, Bunin G, Berlin JA, Baumgarten M, DeMichele A, Rubin SC, Berlin M, Troxel AB, Rebbeck TR. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. American Journal of Epidemiology. 164: 775-86. PMID 16997897 DOI: 10.1093/Aje/Kwj316  0.262
2023 Hernandez AE, Westrick AC, Stoler J, Kesmodel SB, Pinheiro PS, Figueroa M, Kobetz EN, Rebbeck T, Goel N. Associations Between Neighborhood-Level Income and Triple-Negative Breast Cancer in a Majority-Minority Population. Annals of Surgical Oncology. PMID 37978105 DOI: 10.1245/s10434-023-14517-w  0.262
2020 Yuan J, Kensler KH, Hu Z, Zhang Y, Zhang T, Jiang J, Xu M, Pan Y, Long M, Montone KT, Tanyi JL, Fan Y, Zhang R, Hu X, Rebbeck TR, et al. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry. Plos Genetics. 16: e1008641. PMID 32059012 DOI: 10.1371/journal.pgen.1008641  0.262
2015 Tan DS, Mok TS, Rebbeck TR. Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26578615 DOI: 10.1200/JCO.2015.62.0096  0.261
1998 Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J. BRCA1, BRCA2, and Hereditary Nonpolyposis Colorectal Cancer Gene Mutations in an Unselected Ovarian Cancer Population Obstetrical & Gynecological Survey. 53: 477-478. DOI: 10.1097/00006254-199808000-00012  0.261
2018 Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR, Hait WN, Lee JJ, Kensler TW, Kramer BS, Limburg P, ... ... Rebbeck TR, et al. AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prevention Research (Philadelphia, Pa.). 11: 735-778. PMID 30530635 DOI: 10.1158/1940-6207.Capr-18-0421  0.261
2008 Rebbeck T, Troxel AB, Norman S. Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk (American Journal of Epidemiology (2007) 166, (1392-1399)) American Journal of Epidemiology. 167: 888. DOI: 10.1093/aje/kwn048  0.261
2011 Barnholtz-Sloan JS, Raska P, Rebbeck TR, Millikan RC. Replication of GWAS "Hits" by Race for Breast and Prostate Cancers in European Americans and African Americans. Frontiers in Genetics. 2: 37. PMID 22303333 DOI: 10.3389/Fgene.2011.00037  0.26
2003 Martin AM, Kanetsky PA, Amirimani B, Colligon TA, Athanasiadis G, Shih HA, Gerrero MR, Calzone K, Rebbeck TR, Weber BL. Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1? Journal of Medical Genetics. 40. PMID 12676907  0.259
2010 Rebbeck TR, Weber AL, Walker AH, Stefflova K, Tran TV, Spangler E, Chang BL, Zeigler-Johnson CM. Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2115-23. PMID 20826827 DOI: 10.1158/1055-9965.Epi-10-0173  0.258
2019 Mahal BA, Alshalalfa M, Spratt DE, Davicioni E, Zhao SG, Feng FY, Rebbeck TR, Nguyen PL, Huang FW. Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores. European Urology. PMID 30683576 DOI: 10.1016/J.Eururo.2019.01.010  0.258
2014 Yamoah K, Whittemore AS, Malkowicz SB, Spangler E, Kattan MW, Dicker A, Rebbeck TR. The impact of body mass index on treatment recommendations for patients with intermediate risk prostate cancer. Journal of Clinical Oncology. 32: 48-48. DOI: 10.1200/Jco.2014.32.4_Suppl.48  0.258
2007 Apter A, Wan F, Chittams J, Adelsberg B, Andrew S, Blaiss M, Columbo M, Davidson A, Detjen P, De Cotiis B, Dvorin D, Ford L, Gawchik S, Gillman S, Grijnsztein M, ... ... Rebbeck T, et al. Risk Factors For Adults with a History of Penicillin Allergy Journal of Allergy and Clinical Immunology. 119: S269. DOI: 10.1016/J.Jaci.2006.12.421  0.256
2021 Plym A, Dióssy M, Szallasi Z, Sartor O, Silberstein J, Powell IJ, Rebbeck TR, Penney KL, Mucci LA, Pomerantz MM, Kibel AS. DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men. Jnci Cancer Spectrum. 6. PMID 35079693 DOI: 10.1093/jncics/pkab097  0.256
2023 Jalloh M, Cassell A, Niang L, Rebbeck T. Global Viewpoints: Updates on Prostate cancer in Sub-Saharan Africa. Bju International. PMID 37702258 DOI: 10.1111/bju.16178  0.256
2002 Shih HA, Couch FJ, Nathanson KL, Anne Blackwood M, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic Journal of Clinical Oncology. 20: 994-999. PMID 11844822 DOI: 10.1200/Jco.20.4.994  0.255
2004 Rebbeck TR, Martínez ME, Sellers TA, Shields PG, Wild CP, Potter JD. Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1985-6. PMID 15598750  0.255
1998 Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Journal of the National Cancer Institute. 90: 1225-9. PMID 9719084  0.255
2010 Domchek SM, Friebel TM, Rebbeck TR. Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers-reply Jama - Journal of the American Medical Association. 304: 2695-2696. DOI: 10.1001/jama.2010.1855  0.254
2022 Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, Ali Z, Anderson BO, Anorlu R, Avery S, Barango P, Bih N, Booth CM, Brawley OW, Dangou JM, ... ... Rebbeck TR, et al. Cancer in sub-Saharan Africa: a Lancet Oncology Commission. The Lancet. Oncology. PMID 35550267 DOI: 10.1016/S1470-2045(21)00720-8  0.254
2008 Zeigler-Johnson CM, Rennert H, Mittal RD, Jalloh M, Sachdeva R, Malkowicz SB, Mandhani A, Mittal B, Gueye SM, Rebbeck TR. Evaluation of prostate cancer characteristics in four populations worldwide. The Canadian Journal of Urology. 15: 4056-64. PMID 18570709  0.254
2018 Memirie ST, Habtemariam MK, Asefa M, Deressa BT, Abayneh G, Tsegaye B, Abraha MW, Ababi G, Jemal A, Rebbeck TR, Verguet S. Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data. Journal of Global Oncology. 1-11. PMID 30241262 DOI: 10.1200/Jgo.17.00175  0.254
1998 Margolis DJ, Halpern AC, Rebbeck T, Schuchter L, Barnhill RL, Fine J, Berwick M. Validation of a melanoma prognostic model. Archives of Dermatology. 134: 1597-601. PMID 9875200 DOI: 10.1001/Archderm.134.12.1597  0.254
2023 Nguyen DD, Labban M, Briggs L, Wallis CJD, Cole AP, Lipsitz SR, Iyer HS, Rebbeck TR, Weissman JS, Choueiri TK, Trinh QD. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations. Urologic Oncology. PMID 36759298 DOI: 10.1016/j.urolonc.2023.01.011  0.253
2014 Rebbeck TR, Haas GP. Temporal trends and racial disparities in global prostate cancer prevalence. The Canadian Journal of Urology. 21: 7496-506. PMID 25347377  0.253
2019 Chen W, Mahal B, Alshalalfa M, Zhao S, Beltran H, Davicioni E, Karnes R, Ku S, Lotan T, Rebbeck T, Schaeffer E, Feng F, Nguyen P. Associations of Stromal Infiltration with Prognosis and Response to Postoperative Radiotherapy in Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 105: S39. DOI: 10.1016/j.ijrobp.2019.06.458  0.252
2019 Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, ... ... Rebbeck TR, et al. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. PMID 31213659 DOI: 10.1038/S41416-019-0492-8  0.252
2007 Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, ... ... Rebbeck TR, et al. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clinical Breast Cancer. 7: 875-82. PMID 18269778 DOI: 10.3816/CBC.2007.n.053  0.251
2016 Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 18: 15. PMID 26857456 DOI: 10.1186/S13058-016-0671-Y  0.251
2008 Israni AK, Li N, Cizman BB, Snyder J, Abrams J, Joffe M, Rebbeck T, Feldman HI. Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 52: 331-9. PMID 18640487 DOI: 10.1053/J.Ajkd.2008.05.006  0.25
2018 Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, ... ... Rebbeck TR, et al. Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate. Journal of Global Oncology. 1-14. PMID 30260755 DOI: 10.1200/Jgo.18.00063  0.25
2023 Goel N, Hernandez A, Merchant N, Rebbeck T. Translational Epidemiology: Genetic Ancestry in Breast Cancer: What Is the Role of Genetic Ancestry and Socioeconomic Status in Triple-Negative Breast Cancer? Advances in Surgery. 57: 1-14. PMID 37536846 DOI: 10.1016/j.yasu.2023.03.001  0.249
2020 Mahal BA, Alshalalfa M, Zhao SG, Beltran H, Chen WS, Chipidza F, Davicioni E, Karnes RJ, Ku SY, Lotan TL, Muralidhar V, Rebbeck TR, Schaeffer EM, Spratt DE, Feng FY, et al. Genomic and clinical characterization of stromal infiltration markers in prostate cancer. Cancer. PMID 31905251 DOI: 10.1002/Cncr.32688  0.249
1996 Rebbeck TR, Godwin AK, Buetow KH. Variability in loss of constitutional heterozygosity across loci and among individuals: Association with candidate genes in ductal breast carcinoma Molecular Carcinogenesis. 17: 117-125. PMID 8944071 DOI: 10.1002/(Sici)1098-2744(199611)17:3<117::Aid-Mc3>3.0.Co;2-C  0.249
2019 Lu-Yao G, Nikita N, Keith SW, Nightingale G, Gandhi K, Hegarty SE, Rebbeck TR, Chapman A, Kantoff PW, Cullen J, Gomella L, Kelly WK. Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities. European Urology. PMID 31420248 DOI: 10.1016/J.Eururo.2019.07.031  0.249
2017 Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, ... ... Rebbeck TR, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017741173. PMID 29236593 DOI: 10.1200/Jco.2017.74.1173  0.248
2006 Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, ... ... Rebbeck TR, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis. 27: 610-8. PMID 16258177 DOI: 10.1093/Carcin/Bgi252  0.247
2023 Iyer HS, Kensler KH, Vaselkiv JB, Stopsack KH, Roscoe C, Bandera EV, Qin B, Jang TL, Lotan TL, James P, Hart JE, Mucci LA, Laden F, Rebbeck TR. Associations between etiologic or prognostic tumor tissue markers and neighborhood contextual factors in male health professionals diagnosed with prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 37249585 DOI: 10.1158/1055-9965.EPI-23-0217  0.247
2003 Rebbeck TR. Epidemiological approaches to the identification of cancer predisposition genes Methods in Molecular Biology (Clifton, N.J.). 222: 309-325. PMID 12710695  0.245
2021 Leo P, Janowczyk A, Elliott R, Janaki N, Bera K, Shiradkar R, Farré X, Fu P, El-Fahmawi A, Shahait M, Kim J, Lee D, Yamoah K, Rebbeck TR, Khani F, et al. Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study. Npj Precision Oncology. 5: 35. PMID 33941830 DOI: 10.1038/s41698-021-00174-3  0.243
2014 Butts SF, Sammel MD, Greer C, Rebbeck TR, Boorman DW, Freeman EW. Cigarettes, genetic background, and menopausal timing: the presence of single nucleotide polymorphisms in cytochrome P450 genes is associated with increased risk of natural menopause in European-American smokers. Menopause (New York, N.Y.). 21: 694-701. PMID 24448104 DOI: 10.1097/Gme.0000000000000140  0.243
2019 Friebel TM, Andrulis IL, Balmaña J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, ... ... Rebbeck TR, et al. BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry. Human Mutation. PMID 31112363 DOI: 10.1002/Humu.23804  0.243
2023 Pumpalova YS, Ramakrishnan A, May M, Pentz A, Minkowitz S, Doherty S, Singh E, Chen WC, Rebbeck TR, Neugut AI, Joffe M. Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study. Cancer Medicine. PMID 38158645 DOI: 10.1002/cam4.6739  0.242
2001 Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D, Rebbeck TR, Haffty BG, Reed JC. BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer Journal of Clinical Oncology. 19: 992-1000. PMID 11181661  0.242
2022 Awasthi S, Grass GD, Torres-Roca J, Johnstone PAS, Pow-Sang J, Dhillon J, Park J, Rounbehler RJ, Davicioni E, Hakansson A, Liu Y, Fink AK, DeRenzis A, Creed JH, Poch M, ... ... Rebbeck TR, et al. Genomic testing in localized prostate cancer can identify subsets of African-Americans with aggressive disease. Journal of the National Cancer Institute. PMID 36053178 DOI: 10.1093/jnci/djac162  0.241
2012 Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, ... ... Rebbeck TR, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 134-47. PMID 22144499 DOI: 10.1158/1055-9965.Epi-11-0775  0.241
2021 Agalliu I, Lin WJ, Zhang JS, Jacobson JS, Rohan TE, Adusei B, Snyper NYF, Andrews C, Sidahmed E, Mensah JE, Biritwum R, Adjei AA, Okyne V, Ainuson-Quampah J, Fernandez P, ... ... Rebbeck TR, et al. Overall and central obesity and prostate cancer risk in African men. Cancer Causes & Control : Ccc. PMID 34783926 DOI: 10.1007/s10552-021-01515-0  0.24
2008 Rebbeck TR, Rennert H, Walker AH, Panossian S, Tran T, Walker K, Spangler E, Patacsil-Coomes M, Sachdeva R, Wein AJ, Malkowicz SB, Zeigler-Johnson C. Joint effects of inflammation and androgen metabolism on prostate cancer severity. International Journal of Cancer. Journal International Du Cancer. 123: 1385-9. PMID 18566991 DOI: 10.1002/ijc.23687  0.24
2016 Shu CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine DA, Nathanson KL, Konner JA, Arnold AG, Bogomolniy F, Dao F, Olvera N, Bancroft EK, Goldfrank DJ, Stadler ZK, ... ... Rebbeck TR, et al. Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. Jama Oncology. PMID 27367496 DOI: 10.1001/Jamaoncol.2016.1820  0.239
2000 Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 9: 1329-34. PMID 11142418  0.239
2010 Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC. Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Research : Bcr. 12: R28. PMID 20482762 DOI: 10.1186/bcr2576  0.239
2014 Arteaga CL, Adamson PC, Engelman JA, Foti M, Gaynor RB, Hilsenbeck SG, Limburg PJ, Lowe SW, Mardis ER, Ramsey S, Rebbeck TR, Richardson AL, Rubin EH, Weiner GJ. AACR Cancer Progress Report 2014. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: S1-S112. PMID 25228531 DOI: 10.1158/1078-0432.Ccr-14-2123  0.238
2016 Jeffers A, Sochat V, Kattan MW, Yu C, Melcon E, Yamoah K, Rebbeck TR, Whittemore AS. Predicting Prostate Cancer Recurrence After Radical Prostatectomy. The Prostate. PMID 27775165 DOI: 10.1002/Pros.23268  0.237
2011 Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, ... ... Rebbeck TR, et al. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human Genetics. 130: 685-99. PMID 21597964 DOI: 10.1007/S00439-011-1003-Z  0.237
2018 Warner WA, Lee TY, Fang F, Llanos AAM, Bajracharya S, Sundaram V, Badal K, Sookdeo VD, Roach V, Lamont-Greene M, Ragin C, Slovacek S, Ramsoobhag K, Brown J, Rebbeck TR, et al. The burden of prostate cancer in Trinidad and Tobago: one of the highest mortality rates in the world. Cancer Causes & Control : Ccc. PMID 29774450 DOI: 10.1007/s10552-018-1038-8  0.237
2024 Janivara R, Hazra U, Pfennig A, Harlemon M, Kim MS, Eaaswarkhanth M, Chen WC, Ogunbiyi A, Kachambwa P, Petersen LN, Jalloh M, Mensah JE, Adjei AA, Adusei B, Joffe M, ... ... Rebbeck TR, et al. Uncovering the genetic architecture and evolutionary roots of androgenetic alopecia in African men. Biorxiv : the Preprint Server For Biology. PMID 38293167 DOI: 10.1101/2024.01.12.575396  0.237
2014 Rebbeck TR. Precision prevention of cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2713-5. PMID 25362191 DOI: 10.1158/1055-9965.EPI-14-1058  0.236
1995 Lustbader ED, Rebbeck TR, Buetow KH. Using loss of heterozygosity data in affected pedigree member linkage tests Genetic Epidemiology. 12: 339-350. PMID 8536951 DOI: 10.1002/gepi.1370120402  0.236
2007 Rebbeck TR, Khoury MJ, Potter JD. Genetic association studies of cancer: Where do we go from here? Cancer Epidemiology Biomarkers and Prevention. 16: 864-865. PMID 17507606 DOI: 10.1158/1055-9965.Epi-07-0289  0.236
1993 Rebbeck TR, Dietz FR, Murray JC, Buetow KH. A single-gene explanation for the probability of having idiopathic talipes equinovarus American Journal of Human Genetics. 53: 1051-1063. PMID 8213831  0.236
2019 Mahal BA, Butler S, Franco I, Spratt DE, Rebbeck TR, D'Amico AV, Nguyen PL. Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015. Jama. PMID 30743264 DOI: 10.1001/jama.2018.19941  0.236
2006 Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade OI, Weber BL, ... Rebbeck TR, et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. The Lancet. Oncology. 7: 223-9. PMID 16510331 DOI: 10.1016/S1470-2045(06)70585-X  0.236
2016 Ogunbiyi JO, Stefan DC, Rebbeck TR. African Organization for Research and Training in Cancer: position and vision for cancer research on the African Continent. Infectious Agents and Cancer. 11: 63. PMID 27980610 DOI: 10.1186/s13027-016-0110-9  0.235
2017 Adeola HA, Blackburn JM, Rebbeck TR, Zerbini LF. Emerging proteomics biomarkers and prostate cancer burden in Africa. Oncotarget. PMID 28388542 DOI: 10.18632/Oncotarget.16568  0.235
2015 Shu CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine DA, Robson ME, Konner JA, Blum JL, Neuhausen SL, Garber JE, Daly MB, Isaacs C, Eeles RA, Ganz PA, ... ... Rebbeck TR, et al. Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations (BRCA+): A multicenter, prospective study. Journal of Clinical Oncology. 33: 1504-1504. DOI: 10.1200/Jco.2015.33.15_Suppl.1504  0.234
2004 Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC. SNPs, Haplotypes, and cancer: Applications in molecular epidemiology Cancer Epidemiology Biomarkers and Prevention. 13: 681-687. PMID 15159297  0.234
2023 Morley F, Iyer HS, Tamimi RM, Nanus DM, Rebbeck TR, Kensler KH. Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program. Cancer Causes & Control : Ccc. PMID 37878135 DOI: 10.1007/s10552-023-01807-7  0.233
2006 Rebbeck TR. Conquering cancer disparities: New opportunities for cancer epidemiology, biomarker, and prevention research Cancer Epidemiology Biomarkers and Prevention. 15: 1569-1571. PMID 16985011 DOI: 10.1158/1055-9965.EPI-06-0613  0.233
2022 Makau-Barasa LK, Manirakiza A, Carvalho AL, Rebbeck TR. Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis. Cancer Control : Journal of the Moffitt Cancer Center. 29: 10732748221084932. PMID 35350915 DOI: 10.1177/10732748221084932  0.233
2021 Iyer HS, Gomez SL, Chen JT, Trinh QD, Rebbeck TR. Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position. Cancer. PMID 33798264 DOI: 10.1002/cncr.33506  0.232
2020 Yamoah K, Awasthi S, Mahal BA, Zhao SG, Grass GD, Berglund A, Abraham-Miranda J, Gerke T, Rounbehler RJ, Davicioni E, Liu Y, Park J, Cleveland JL, Pow-Sang JM, Fernandez D, ... ... Rebbeck TR, et al. Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer. European Urology. PMID 33303244 DOI: 10.1016/j.eururo.2020.11.038  0.232
2010 Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer. 116: 2416-2428. PMID 20301115 DOI: 10.1002/cncr.24994  0.231
2020 Yamoah K, Lal P, Awasthi S, Naghavi AO, Rounbehler RJ, Gerke T, Berglund AE, Pow-Sang JM, Schaeffer EM, Dhillon J, Park JY, Rebbeck TR. TMPRSS2-ERG fusion impact anterior tumor location in men with prostate cancer. The Prostate. PMID 33141952 DOI: 10.1002/pros.24086  0.231
2020 Fadelu T, Damuse R, Lormil J, Pecan E, Greenberg L, Dubuisson C, Pierre V, Triedman SA, Shulman LN, Rebbeck TR. Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast Cancer. Jco Global Oncology. 6: 1656-1665. PMID 33151773 DOI: 10.1200/GO.20.00307  0.23
2019 Butler SS, Muralidhar V, Zhao SG, Sanford NN, Franco I, Fullerton ZH, Chavez J, D'Amico AV, Feng FY, Rebbeck TR, Nguyen PL, Mahal BA. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012. Cancer. PMID 31794057 DOI: 10.1002/cncr.32604  0.23
2009 Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, ... ... Rebbeck TR, et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. International Journal of Cancer. Journal International Du Cancer. 124: 420-8. PMID 18792098 DOI: 10.1002/Ijc.23869  0.23
2022 Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, Esener S, Fitzgerald RC, Gambhir SS, Kuhn P, Rebbeck TR, Balasubramanian S. Early detection of cancer. Science (New York, N.Y.). 375: eaay9040. PMID 35298272 DOI: 10.1126/science.aay9040  0.229
2022 Raoof S, Lee RJ, Jajoo K, Mancias JD, Rebbeck TR, Skates SJ. Multi-cancer early detection technologies: a review informed by past cancer screening studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35320352 DOI: 10.1158/1055-9965.EPI-21-1443  0.228
2022 Withrow D, Pilleron S, Nikita N, Ferlay J, Sharma S, Nicholson B, Rebbeck TR, Lu-Yao G. Current and projected number of years of life lost due to prostate cancer: A global study. The Prostate. PMID 35468227 DOI: 10.1002/pros.24360  0.228
2013 Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013: 560857. PMID 23476788 DOI: 10.1155/2013/560857  0.227
2018 Rebbeck TR, Burns-White K, Chan AT, Emmons K, Freedman M, Hunter DJ, Kraft P, Laden F, Mucci L, Parmigiani G, Schrag D, Syngal S, Tamimi RM, Viswanath K, Yurgelun MB, et al. Precision Prevention and Early Detection of Cancer: Fundamental Principles. Cancer Discovery. PMID 29907587 DOI: 10.1158/2159-8290.Cd-17-1415  0.226
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prevention Research (Philadelphia, Pa.). 1: 393-5. PMID 19138984 DOI: 10.1158/1940-6207.Capr-08-0176  0.226
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2903-5. PMID 18990728 DOI: 10.1158/1055-9965.Epi-08-0888  0.226
2023 Alaniz M, Rebbeck TR. The role of community outreach and engagement in evaluation of NCI Cancer Center Support Grants. Cancer Causes & Control : Ccc. PMID 37563423 DOI: 10.1007/s10552-023-01770-3  0.226
2020 Solsky I, Chen J, Rebbeck TR. Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations. Gynecologic Oncology. PMID 31918993 DOI: 10.1016/j.ygyno.2019.11.036  0.225
2023 Hernandez AE, Westrick AC, Stoler J, Kesmodel SB, Pinheiro PS, Figueroa ME, Kobetz EN, Rebbeck T, Goel N. ASO Visual Abstract: Associations Between Neighborhood-Level Income and Triple-Negative Breast Cancer in a Majority-Minority Population. Annals of Surgical Oncology. PMID 38071707 DOI: 10.1245/s10434-023-14666-y  0.225
2019 Chen WS, Alshalalfa M, Zhao SG, Liu Y, Mahal BA, Quigley DA, Wei T, Davicioni E, Rebbeck TR, Kantoff PW, Maher CA, Knudsen KE, Small EJ, Nguyen PL, Feng FY. Novel RB1-loss transcriptomic signature is associated with poor clinical outcomes across cancer types. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31010837 DOI: 10.1158/1078-0432.Ccr-19-0404  0.225
2016 Yamoah K, Lal P, Mahajan S, Naghavi A, Rebbeck T. Clinical Implications of TMPRSS2-ERG Fusion in African American Men With Localized Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 96: E569. DOI: 10.1016/j.ijrobp.2016.06.2052  0.224
2014 Spurdle AB, Couch FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, ... ... Rebbeck TR, et al. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research : Bcr. 16: 3419. PMID 25857409 DOI: 10.1186/S13058-014-0474-Y  0.223
2004 Deitz AC, Rothman N, Rebbeck TR, Hayes RB, Chow WH, Zheng W, Hein DW, García-Closas M. Impact of misclassification in genotype-exposure interaction studies: Example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer Cancer Epidemiology Biomarkers and Prevention. 13: 1543-1546. PMID 15342459  0.222
2013 Morhason-Bello IO, Odedina F, Rebbeck TR, Harford J, Dangou JM, Denny L, Adewole IF. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. The Lancet. Oncology. 14: e142-51. PMID 23561745 DOI: 10.1016/S1470-2045(12)70482-5  0.221
2018 Awasthi S, Gerke T, Park JY, Asamoah FA, Williams VL, Fink AK, Balkrishnan R, Lee DI, Malkowicz SB, Lal P, Dhillon J, Pow-Sang JM, Rebbeck TR, Yamoah K. Optimizing Time-to-Treatment to achieve durable biochemical disease control after surgery in prostate cancer - A multi-institutional cohort study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30413401 DOI: 10.1158/1055-9965.Epi-18-0812  0.221
2008 Jalloh M, Zeigler-Johnson C, Sylla-Niang M, Niang L, Labou I, Konte KA, Rebbeck TR, Gueye S. A study of PSA values in an unselected sample of Senegalese men. The Canadian Journal of Urology. 15: 3883-5. PMID 18304398  0.221
2016 Patel VL, Busch E, D'Amico AV, Rebbeck TR. BRCA2 Mutations in Prostate Cancer Assort Into Cluster Regions. International Journal of Radiation Oncology, Biology, Physics. 96: E569-E570. PMID 27675040 DOI: 10.1016/j.ijrobp.2016.06.2054  0.219
2021 Wu C, Zhu J, King A, Tong X, Lu Q, Park JY, Wang L, Gao G, Deng HW, Yang Y, Knudsen KE, Rebbeck TR, Long J, Zheng W, Pan W, et al. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer Communications (London, England). PMID 34520132 DOI: 10.1002/cac2.12205  0.219
2013 Adesina A, Chumba D, Nelson AM, Orem J, Roberts DJ, Wabinga H, Wilson M, Rebbeck TR. Improvement of pathology in sub-Saharan Africa. The Lancet. Oncology. 14: e152-7. PMID 23561746 DOI: 10.1016/S1470-2045(12)70598-3  0.219
2015 Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB, Dwyer T, Gallagher RP, Gruber SB, Orlow I, Rosso S, Thomas NE, Zanetti R, Rebbeck TR, et al. Inherited variation at MC1R and histological characteristics of primary melanoma. Plos One. 10: e0119920. PMID 25790105 DOI: 10.1371/Journal.Pone.0119920  0.219
2015 Taylor NJ, Reiner AS, Begg CB, Cust AE, Busam KJ, Anton-Culver H, Dwyer T, From L, Gallagher RP, Gruber SB, Rosso S, White KA, Zanetti R, Orlow I, Thomas NE, ... Rebbeck TR, et al. Inherited variation at MC1R and ASIP and association with melanoma-specific survival. International Journal of Cancer. Journal International Du Cancer. 136: 2659-67. PMID 25382380 DOI: 10.1002/Ijc.29317  0.218
2019 Alshalalfa M, Nguyen PL, Beltran H, Chen WS, Davicioni E, Zhao SG, Rebbeck TR, Schaeffer EM, Lotan TL, Feng FY, Mahal BA. Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications. European Urology Oncology. PMID 31164324 DOI: 10.1016/J.Euo.2019.05.001  0.218
2006 Begg C, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, et al. A design for cancer case-control studies using only incident cases: Experience with the GEM study of melanoma International Journal of Epidemiology. 35: 756-764. PMID 16556646 DOI: 10.1093/Ije/Dyl044  0.216
2016 Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman SM. Leveraging premalignant biology for immune-based cancer prevention. Proceedings of the National Academy of Sciences of the United States of America. PMID 27638202 DOI: 10.1073/Pnas.1608077113  0.216
2019 Yao G, Nikita N, Keith S, Nightingale G, Gandhi K, Rebbeck T, Chapman A, Kantoff P, Cullen J, Kelly W. SHORT-TERM OUTCOMES FOLLOWING ORAL HORMONAL PROSTATE CANCER THERAPIES BY PRE-EXISTING CARDIOVASCULAR CONDITIONS: A POPULATION-BASED STUDY Journal of Geriatric Oncology. 10: S72. DOI: 10.1016/S1879-4068(19)31238-X  0.215
2001 Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma Cancer Epidemiology Biomarkers and Prevention. 10: 509-513. PMID 11352862  0.215
2004 Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 808-19. PMID 15159314  0.215
2016 Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. Bmc Cancer. 16: 557. PMID 27473687 DOI: 10.1186/S12885-016-2572-Y  0.214
2018 Iyer H, James P, Valeri L, Hart JE, Laden F, Holmes M, Rebbeck T. The Association between Long-term Neighborhood Greenness and Lethal Prostate Cancer in a Prospective Cohort Study of Male Health Professionals in the United States Isee Conference Abstracts. 2018. DOI: 10.1289/isesisee.2018.o04.02.24  0.214
2020 Kensler KH, Pernar CH, Mahal BA, Nguyen PL, Trinh QD, Kibel AS, Rebbeck TR. Racial/ethnic variation in PSA testing and prostate cancer incidence following the 2012 U.S.P.S.T.F. recommendation. Journal of the National Cancer Institute. PMID 33146392 DOI: 10.1093/jnci/djaa171  0.214
2003 Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology. 61: 987-92. PMID 12736021 DOI: 10.1016/S0090-4295(02)02588-8  0.214
2007 Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Association of Obesity With Tumor Characteristics and Treatment Failure of Prostate Cancer in African-American and European American Men Journal of Urology. 178: 1939-1945. PMID 17868722 DOI: 10.1016/j.juro.2007.07.021  0.214
2006 Rebbeck TR. Inherited genetic markers and cancer outcomes: Personalized medicine in the postgenome era Journal of Clinical Oncology. 24: 1972-1974. PMID 16648495 DOI: 10.1200/JCO.2005.05.1532  0.214
2018 Adeloye D, Harhay MO, Ayepola OO, Dos Santos JP, David RA, Ogunlana OO, Gadanya M, Osamor VC, Amuta AO, Iweala EE, Auta A, Rebbeck TR. Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis. International Journal of Urology : Official Journal of the Japanese Urological Association. PMID 30345565 DOI: 10.1111/iju.13824  0.213
2023 Ramaswamy M, Manz C, Kouyoumdjian F, Vest N, Puglisi L, Wang E, Salyer C, Osei B, Zaller N, Rebbeck TR. Cancer equity for those impacted by mass incarceration. Journal of the National Cancer Institute. PMID 37219371 DOI: 10.1093/jnci/djad087  0.213
2022 Oehrlein N, Streicher SA, Kuo HC, Chaurasia A, McFadden J, Nousome D, Chen Y, Stroup SP, Musser J, Brand T, Porter C, Rosner IL, Chesnut GT, Onofaro KC, Rebbeck TR, et al. Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017. Cancer Medicine. PMID 35638719 DOI: 10.1002/cam4.4787  0.213
2006 Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: An international population-based study Cancer Epidemiology Biomarkers and Prevention. 15: 1520-1525. PMID 16896043 DOI: 10.1158/1055-9965.Epi-06-0270  0.213
2000 Kim C, Gumbs A, Komarnicky L, Carter D, Hutter R, Palazzo J, McCue P, Goodman R, Haffty B, Rebbeck T, Weber B, Turner B. Predicted germline BRCA1/BRCA2 mutations and second primary ipsilateral breast cancers in young women with pure ductal carcinoma in-situ treated with breast conserving therapy International Journal of Radiation Oncology*Biology*Physics. 48: 142-143. DOI: 10.1016/S0360-3016(00)80079-6  0.211
2021 Yamoah K, Asamoah FA, Abrahams AOD, Awasthi S, Mensah JE, Dhillon J, Mahal BA, Gueye SM, Jalloh M, Farahani SJ, Lal P, Rebbeck TR, Yarney J. Prostate tumors of native men from West Africa show biologically distinct pathways-A comparative genomic study. The Prostate. PMID 34529278 DOI: 10.1002/pros.24238  0.211
2009 Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. American Journal of Epidemiology. 170: 269-79. PMID 19498075 DOI: 10.1093/aje/kwp119  0.209
2008 Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, et al. Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. American Journal of Public Health. 98: 1608-15. PMID 18633099 DOI: 10.2105/Ajph.2006.102525  0.209
2013 Jalloh M, Friebel TM, Sira Thiam F, Niang L, Sy C, Siby T, Fernandez P, Mapulanga V, Maina S, Doodu Mante S, Yeboah E, Kyei M, Ankomah R, Amegbor J, Adusei B, ... ... Rebbeck TR, et al. Evaluation of 4, 672 routine prostate biopsies performed in six African countries Journal Africain Du Cancer. 5: 144-154. DOI: 10.1007/S12558-013-0264-Y  0.209
2023 Iyer HS, Shi X, Satagopan JM, Cheng I, Roscoe C, McLaughlin RH, Stroup AM, Setoguchi S, Bandera EV, Hernandez BY, Doherty JA, Hsieh MC, Knowlton R, Qin B, Laden F, ... Rebbeck TR, et al. Advancing Social and Environmental Research in Cancer Registries Using Geomasking for Address-Level Data. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 32: 1485-1489. PMID 37908192 DOI: 10.1158/1055-9965.EPI-23-0790  0.208
2006 Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2437-43. PMID 16636335 DOI: 10.1200/Jco.2005.02.7888  0.207
2022 Sponholtz TR, Palmer JR, Rosenberg L, Chen C, Chen Y, Clarke MA, Clendenen T, Du M, Johnson L, Liao LM, Michels KA, O'Connell K, Olson SH, Petruzella S, Rebbeck TR, et al. Risk factors for endometrial cancer in Black women. Cancer Causes & Control : Ccc. PMID 36418803 DOI: 10.1007/s10552-022-01653-z  0.206
2020 Iyer HS, Valeri L, James P, Chen JT, Hart JE, Laden F, Holmes MD, Rebbeck TR. The contribution of residential greenness to mortality among men with prostate cancer: a registry-based cohort study of Black and White men. Environmental Epidemiology (Philadelphia, Pa.). 4: e087. PMID 32337472 DOI: 10.1097/EE9.0000000000000087  0.205
2016 Rebbeck TR. Defining Priorities for Reducing Disparities in Cancer Mortality. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 570-2. PMID 27196088 DOI: 10.1158/1055-9965.EPI-15-1244  0.205
2006 Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR. Members of the glutathione (GSH) and ABC-transporter families are associated with clinical outcomes in patients with diffuse large B-cell lymphoma (DLCL) Journal of Clinical Oncology. 24: 10035-10035. DOI: 10.1200/Jco.2006.24.18_Suppl.10035  0.204
2021 Cole AP, Herzog P, Iyer HS, Marchese M, Mahal BA, Lipsitz SR, Nyambose J, Gershman ST, Kennedy M, Merriam G, Rebbeck TR, Trinh QD. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts. Cancer. PMID 33999405 DOI: 10.1002/cncr.33564  0.204
2015 Yamoah K, Walker A, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Dicker AP, Rebbeck TR, Lal P. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy. Clinical Genitourinary Cancer. 13: e65-72. PMID 25450037 DOI: 10.1016/j.clgc.2014.08.012  0.204
2020 Kripke M, Brody JG, Hawk E, Hernandez AB, Hoppin PJ, Jacobs MM, Rudel RA, Rebbeck TR. Rethinking Environmental Carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 29: 1870-1875. PMID 33004408 DOI: 10.1158/1055-9965.EPI-20-0541  0.204
2018 Warner WA, Lee TY, Badal K, Williams TM, Bajracharya S, Sundaram V, Bascombe NA, Maharaj R, Lamont-Greene M, Roach A, Bondy M, Ellis MJ, Rebbeck TR, Slovacek S, Luo J, et al. Cancer incidence and mortality rates and trends in Trinidad and Tobago. Bmc Cancer. 18: 712. PMID 29973176 DOI: 10.1186/S12885-018-4625-X  0.204
2008 Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL. The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Research. 68: 7006-14. PMID 18703817 DOI: 10.1158/0008-5472.Can-08-0599  0.203
2021 Labaki C, Bakouny Z, Schmidt A, Lipsitz SR, Rebbeck TR, Trinh QD, Choueiri TK. Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic. Cancer Cell. PMID 34265251 DOI: 10.1016/j.ccell.2021.06.019  0.202
2017 Busch EL, Hornick JL, Umeton R, Albayrak A, Lindeman NI, MacConaill LE, Garcia EP, Ducar M, Rebbeck TR. Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites. Oncotarget. 8: 85680-85691. PMID 29156750 DOI: 10.18632/oncotarget.21115  0.202
2020 Awasthi S, Berglund AE, Abraham-Miranda J, Rounbehler RJ, Kensler KH, Serna AN, Vidal AC, You S, Freeman MR, Davicioni E, Liu Y, Karnes JR, Klein EA, Den RB, Trock BJ, ... ... Rebbeck TR, et al. Comparative genomics reveals distinct immune-oncologic pathways in African American men with prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33037017 DOI: 10.1158/1078-0432.CCR-20-2925  0.201
2006 Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma Cancer Research. 66: 9330-9337. PMID 16982779 DOI: 10.1158/0008-5472.Can-06-1634  0.2
2021 Leo P, Chandramouli S, Farré X, Elliott R, Janowczyk A, Bera K, Fu P, Janaki N, El-Fahmawi A, Shahait M, Kim J, Lee D, Yamoah K, Rebbeck TR, Khani F, et al. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2. European Urology Focus. PMID 33941504 DOI: 10.1016/j.euf.2021.04.016  0.2
2022 Kensler KH, Awasthi S, Alshalalfa M, Trock BJ, Freedland SJ, Freeman MR, You S, Mahal BA, Den RB, Dicker AP, Karnes RJ, Klein EA, Lal P, Liu Y, Davicioni E, ... ... Rebbeck TR, et al. Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race. European Urology Open Science. 40: 19-26. PMID 35638091 DOI: 10.1016/j.euros.2022.03.014  0.199
2023 Iyer HS, Vaselkiv JB, Stopsack KH, Roscoe CJ, DeVille NV, Zhang Y, Penney KL, Balk SP, Fiorentino M, Hart JE, James P, De Vivo I, Mucci LA, Laden F, Rebbeck TR. Influence of neighborhood social and natural environment on prostate tumor histology in a cohort of male health professionals. American Journal of Epidemiology. PMID 37139568 DOI: 10.1093/aje/kwad112  0.197
2011 Rebbeck TR, Zeigler-Johnson CM, Heyns CF, Gueye SM. Prostate cancer screening, detection and treatment practices, among Sub-Saharan African urologists African Journal of Urology. 17: 85-91. DOI: 10.1007/s12301-011-0016-0  0.197
2002 Kanetsky PA, Swoyer J, Panossian S, Holmes R, Guerry D, Rebbeck TR. A polymorphism in the agouti signaling protein gene is associated with human pigmentation American Journal of Human Genetics. 70: 770-775. PMID 11833005 DOI: 10.1086/339076  0.197
2006 Rebbeck TR, Halbert CH, Sankar P. Genetics, epidemiology, and cancer disparities: Is it black and white? Journal of Clinical Oncology. 24: 2164-2169. PMID 16682735 DOI: 10.1200/JCO.2005.05.1656  0.197
2008 Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing. 12: 81-91. PMID 18373407 DOI: 10.1089/Gte.2007.0037  0.197
2019 Sanford NN, Sher DJ, Butler S, Xu X, Ahn C, D'Amico AV, Rebbeck T, Aizer AA, Mahal BA. Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015. Jama Network Open. 2: e193759. PMID 31099863 DOI: 10.1001/jamanetworkopen.2019.3759  0.196
2015 Nelson AM, Milner DA, Rebbeck TR, Iliyasu Y. Oncologic Care and Pathology Resources in Africa: Survey and Recommendations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26578619 DOI: 10.1200/JCO.2015.61.9767  0.195
2020 Rebbeck TR. Cancer in sub-Saharan Africa. Science (New York, N.Y.). 367: 27-28. PMID 31896706 DOI: 10.1126/science.aay4743  0.195
2020 Jordan SJ, Na R, Weiderpass E, Adami HO, Anderson KE, van den Brandt PA, Brinton LA, Chen C, Cook LS, Doherty JA, Du M, Friedenreich CM, Gierach GL, Goodman MT, Krogh V, ... ... Rebbeck TR, et al. Pregnancy Outcomes and Risk of Endometrial Cancer: A Pooled Analysis of Individual Participant Data in the Epidemiology of Endometrial Cancer Consortium. International Journal of Cancer. PMID 33105052 DOI: 10.1002/ijc.33360  0.194
2014 Adewole I, Martin DN, Williams MJ, Adebamowo C, Bhatia K, Berling C, Casper C, Elshamy K, Elzawawy A, Lawlor RT, Legood R, Mbulaiteye SM, Odedina FT, Olopade OI, Olopade CO, ... ... Rebbeck TR, et al. Building capacity for sustainable research programmes for cancer in Africa. Nature Reviews. Clinical Oncology. 11: 251-9. PMID 24614139 DOI: 10.1038/Nrclinonc.2014.37  0.193
1994 Rebbeck TR, Lustbader ED, Buetow KH. Somatic allele loss in genetic linkage analysis of cancer Genetic Epidemiology. 11: 419-429. PMID 7835688 DOI: 10.1002/gepi.1370110504  0.192
2024 Wadhwa A, Roscoe C, Duran EA, Kwan L, Haroldsen CL, Shelton JB, Cullen J, Knudsen BS, Rettig MB, Pyarajan S, Nickols NG, Maxwell KN, Yamoah K, Rose BS, Rebbeck TR, et al. Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems. Jama Network Open. 7: e242852. PMID 38502125 DOI: 10.1001/jamanetworkopen.2024.2852  0.191
2012 Roberts DJ, Wilson ML, Nelson AM, Adesina AM, Fleming KA, Milner D, Guarner J, Rebbeck TR, Castle P, Lucas S. The good news about cancer in developing countries--pathology answers the call. Lancet. 379: 712. PMID 22364759 DOI: 10.1016/S0140-6736(12)60306-7  0.191
2022 Fadelu TA, Erfani P, Lormil J, Damuse R, Pierre V, Slater S, Triedman SA, Shulman LN, Rebbeck TR. Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer. Breast Cancer Research and Treatment. PMID 35420316 DOI: 10.1007/s10549-022-06582-8  0.191
2011 Kang G, Gao G, Shete S, Redden DT, Chang BL, Rebbeck TR, Barnholtz-Sloan JS, Pajewski NM, Allison DB. Capitalizing on admixture in genome-wide association studies: a two-stage testing procedure and application to height in African-Americans. Frontiers in Genetics. 2. PMID 21754915 DOI: 10.3389/Fgene.2011.00011  0.191
2007 Domchek SM, Simon MS, Hughes Halbert C, Rebbeck TR, Nathanson KL. Pathologic predictors of BRCA1/ BRCA2 (B1/B2) mutations in African-American (AA) women with early-onset breast cancer (BC) Journal of Clinical Oncology. 25: 10549-10549. DOI: 10.1200/Jco.2007.25.18_Suppl.10549  0.19
2007 Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, ... ... Rebbeck TR, et al. CDKN2A germline mutations in individuals with cutaneous malignant melanoma. The Journal of Investigative Dermatology. 127: 1234-43. PMID 17218939 DOI: 10.1038/Sj.Jid.5700689  0.19
2023 Schuster ALR, Crossnohere NL, Bachini M, Blair CK, Carpten JD, Claus EB, Colditz GA, Ding L, Drake BF, Fields RC, Janeway KA, Kwan BM, Lenz HJ, Ma Q, Mishra SI, ... ... Rebbeck TR, et al. Priorities to promote participant engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36791345 DOI: 10.1158/1055-9965.EPI-22-0356  0.189
2022 Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI, Fishman DS, Golan T, Hidalgo M, Kwon RS, Riegert-Johnson DL, Sahani DV, Stoffel EM, Vollmer CM, Qumseya BJ. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointestinal Endoscopy. PMID 35183358 DOI: 10.1016/j.gie.2021.12.001  0.188
2022 Iyer HS, Gomez SL, Cheng I, Rebbeck TR. Relative impact of genetic ancestry and neighborhood socioeconomic status on all-cause mortality in self-identified African Americans. Plos One. 17: e0273735. PMID 36037186 DOI: 10.1371/journal.pone.0273735  0.187
2018 Odiaka E, Lounsbury DW, Jalloh M, Adusei B, Diallo TA, Kane PMS, Rockson I, Okyne V, Irusen H, Pentz A, Makinde I, Ajibola OH, Petersen L, McBride J, Petersen DC, ... ... Rebbeck TR, et al. Effective Project Management of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate (MADCaP). Journal of Global Oncology. 1-12. PMID 30260756 DOI: 10.1200/Jgo.18.00062  0.185
2017 Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ, Huttenhower C, Irizarry RA, Kip NS, Michor F, Nevo D, et al. Proceedings of the third international molecular pathological epidemiology (MPE) meeting. Cancer Causes & Control : Ccc. PMID 28097472 DOI: 10.1007/s10552-016-0845-z  0.185
1997 Rebbeck TR, Jordan HA, Schnur RE, Rogatko A. Utility of linked markers in genetic counseling: estimation of carrier risks in X-linked ocular albinism. American Journal of Medical Genetics. 70: 58-66. PMID 9129743 DOI: 10.1002/(SICI)1096-8628(19970502)70:1<58::AID-AJMG12>3.0.CO;2-W  0.184
2015 Ochs-Balcom HM, Phillips LS, Nichols HB, Martinez E, Thompson B, Ojeifo J, Rebbeck TR. Building a funded research program in cancer health disparities: considerations for young investigators. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 882-5. PMID 25934837 DOI: 10.1158/1055-9965.Epi-15-0136  0.183
2021 Fadelu T, Rebbeck TR. The rising burden of cancer in low- and middle-human development index countries. Cancer. PMID 34086352 DOI: 10.1002/cncr.33586  0.183
1998 Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, Lovett BD, Nowell PC, Blair IA, Rebbeck TR. Association of CYP3A4 genotype with treatment-related leukemia. Proceedings of the National Academy of Sciences of the United States of America. 95: 13176-81. PMID 9789061 DOI: 10.1073/Pnas.95.22.13176  0.182
2003 Martin AM, Athanasiadis G, Greshock JD, Fisher J, Lux MP, Calzone K, Rebbeck TR, Weber BL. Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes Human Heredity. 55: 171-178. PMID 14566095 DOI: 10.1159/000073201  0.181
2014 Rebbeck TR. The next twenty years: Predicting and preparing for the future cancer landscape in Sub-Saharan Africa Journal Africain Du Cancer / African Journal of Cancer. DOI: 10.1007/s12558-014-0331-z  0.178
2022 Calderwood AH, Sawhney MS, Thosani NC, Rebbeck TR, Wani S, Canto MI, Fishman DS, Golan T, Hidalgo M, Kwon RS, Riegert-Johnson DL, Sahani DV, Stoffel EM, Vollmer CM, Al-Haddad MA, et al. American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence. Gastrointestinal Endoscopy. PMID 35183359 DOI: 10.1016/j.gie.2021.12.002  0.176
2018 Harmsen MG, Piek JMJ, Bulten J, Casey MJ, Rebbeck TR, Mourits MJ, Greene MH, Slangen BFM, van Beurden M, Massuger LFAG, Hoogerbrugge N, de Hullu JA. Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers. Cancer. PMID 29315498 DOI: 10.1002/cncr.31211  0.176
2012 Cabral WA, Barnes AM, Adeyemo A, Cushing K, Chitayat D, Porter FD, Panny SR, Gulamali-Majid F, Tishkoff SA, Rebbeck TR, Gueye SM, Bailey-Wilson JE, Brody LC, Rotimi CN, Marini JC. A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 543-51. PMID 22281939 DOI: 10.1038/Gim.2011.44  0.175
2022 Yao S, Campbell PT, Ugai T, Gierach G, Abubakar M, Adalsteinsson V, Almeida J, Brennan P, Chanock S, Golub T, Hanash S, Harris C, Hathaway CA, Kelsey K, Landi MT, ... ... Rebbeck TR, et al. Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. Cancer Causes & Control : Ccc. PMID 35759080 DOI: 10.1007/s10552-022-01594-7  0.175
2021 Wang C, Zhang Z, Chong W, Luo R, Myers RE, Gu J, Lin J, Wei Q, Li B, Rebbeck TR, Lu-Yao G, Kelly WK, Yang H. Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers. 13. PMID 33450815 DOI: 10.3390/cancers13020268  0.174
2009 Kang HJ, Feng Z, Sun Y, Atwal G, Murphy ME, Rebbeck TR, Rosenwaks Z, Levine AJ, Hu W. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proceedings of the National Academy of Sciences of the United States of America. 106: 9761-6. PMID 19470478 DOI: 10.1073/pnas.0904280106  0.173
2024 Hantel A, Brunner AM, Plascak JJ, Uno H, Varela JC, Luskin MR, Rebbeck TR, Stone RM, Lathan CS, DeAngelo DJ, Abel GA. Race/ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia. Journal of the National Cancer Institute. PMID 38518098 DOI: 10.1093/jnci/djae067  0.173
2013 Zeigler-Johnson C, Weber A, Glanz K, Spangler E, Rebbeck TR. Gender- and ethnic-specific associations with obesity: individual and neighborhood-level factors. Journal of the National Medical Association. 105: 173-82. PMID 24079218  0.172
2022 Kensler KH, Baichoo S, Pathania S, Rebbeck TR. The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer. Npj Precision Oncology. 6: 39. PMID 35715489 DOI: 10.1038/s41698-022-00284-6  0.171
1991 Rebbeck TR, Turner ST, Michels VV, Moll PP. Genetic and environmental explanations for the distribution of sodium-lithium countertransport in pedigrees from Rochester, MN. American Journal of Human Genetics. 48: 1092-104. PMID 2035530  0.171
2005 Rebbeck TR. Commentary: Use of hormone replacement therapy after bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers Hereditary Cancer in Clinical Practice. 3: 91-93.  0.17
2000 Rebbeck TR. More about: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 [1] Journal of the National Cancer Institute. 92: 76. PMID 10620637  0.17
2004 Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick MR. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases Cancer Causes and Control. 15: 957-965. PMID 15577298 DOI: 10.1007/S10522-004-2474-2  0.169
2004 Rebbeck TR, Spitz M, Wu X. Assessing the function of genetic variants in candidate gene association studies Nature Reviews Genetics. 5: 589-597. PMID 15266341 DOI: 10.1038/Nrg1403  0.169
2007 Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood. 109: 3409-16. PMID 17179223 DOI: 10.1182/Blood-2006-09-047621  0.169
2021 Swami N, Hwang WL, Guo JA, Hoffman H, Abramowitz MC, Elbakouny Z, Beltran H, Chipidza F, Choueiri T, Pra AD, Huang F, Kaochar S, Kantoff P, Kim DW, Kishan AU, ... ... Rebbeck TR, et al. Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE). Cancer Genetics. 258: 61-68. PMID 34551377 DOI: 10.1016/j.cancergen.2021.08.004  0.169
2007 Mushlin RA, Kershenbaum A, Gallagher ST, Rebbeck TR. A graph-theoretical approach for pattern discovery in epidemiological research Ibm Systems Journal. 46: 135-149. DOI: 10.1147/sj.461.0135  0.168
1997 Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Brodeur GM. Molecular genetic analysis of familial neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 33: 1923-8. PMID 9516825 DOI: 10.1016/S0959-8049(97)00265-7  0.167
2013 Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Strom BL, ... ... Rebbeck TR, et al. Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2607-18. PMID 23733771 DOI: 10.1200/Jco.2012.48.2596  0.167
2013 Lynch SM, Rebbeck TR. Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 485-95. PMID 23462925 DOI: 10.1158/1055-9965.EPI-13-0010  0.167
2008 Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. International Journal of Epidemiology. 37: 120-32. PMID 17898028 DOI: 10.1093/Ije/Dym159  0.164
2024 Lee DJ, El-Khoury H, Tramontano AC, Alberge JB, Perry J, Davis MI, Horowitz E, Redd RA, Sakrikar D, Barnidge D, Perkins MC, Harding S, Mucci L, Rebbeck TR, Ghobrial IM, et al. Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population. Blood Advances. PMID 38212245 DOI: 10.1182/bloodadvances.2023010843  0.164
2001 Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics. 11: 57-68. PMID 11207031 DOI: 10.1097/00008571-200102000-00007  0.164
2018 Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, et al. Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. Human Mutation. PMID 29446198 DOI: 10.1002/Humu.23406  0.164
2012 Zeigler-Johnson C, Weber A, Spangler E, Panossian S, Rebbeck TR, Malkowicz SB. Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy. The Prostate. 72: 984-90. PMID 22025404 DOI: 10.1002/pros.21503  0.163
2009 Stefflova K, Dulik MC, Pai AA, Walker AH, Zeigler-Johnson CM, Gueye SM, Schurr TG, Rebbeck TR. Evaluation of group genetic ancestry of populations from Philadelphia and Dakar in the context of sex-biased admixture in the Americas. Plos One. 4: e7842. PMID 19946364 DOI: 10.1371/Journal.Pone.0007842  0.158
2022 Erfani P, Bates M, Garcia-Gonzalez P, Milner DA, Rebbeck TR, Ruhangaza D, Shulman LN, Fadelu T. Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap. Jco Global Oncology. 8: e2200182. PMID 36252158 DOI: 10.1200/GO.22.00182  0.157
2003 Amirimani B, Ning B, Deitz AC, Weber BL, Kadlubar FF, Rebbeck TR. Increased Transcriptional Activity of the CYP3A4* 1B Promoter Variant Environmental and Molecular Mutagenesis. 42: 299-305. PMID 14673875 DOI: 10.1002/Em.10199  0.154
2006 Kanetsky PA, Rebbeck TR. Low-penetrance genotypes, pigmentation phenotypes, and melanoma etiology From Melanocytes to Melanoma: the Progression to Malignancy. 347-364. DOI: 10.1007/978-1-59259-994-3_19  0.154
2018 Barcelos MRB, Nunes BP, Duro SMS, Tomasi E, Lima RdCD, Chalupowski MN, Rebbeck TR, Facchini LA. Utilization of Breast Cancer Screening in Brazil: An External Assessment of Primary Health Care Access and Quality Improvement Program Health Systems & Reform. 4: 42-55. DOI: 10.1080/23288604.2017.1405770  0.153
2020 Marinac CR, Ghobrial IM, Birmann BM, Soiffer J, Rebbeck TR. Dissecting racial disparities in multiple myeloma. Blood Cancer Journal. 10: 19. PMID 32066732 DOI: 10.1038/s41408-020-0284-7  0.152
2021 Erhunmwunsee L, Seewaldt VL, Rebbeck TR, Winn RA. From COVID-19 to cancer, watching social determinants decide life: When will we stop spectating? Journal of the National Medical Association. PMID 33726916 DOI: 10.1016/j.jnma.2021.02.003  0.151
1999 Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure Circulation. 99: 1422-1425. PMID 10086964  0.151
2002 Rebbeck TR, Kanetsky PA, Walker AH, Holmes R, Halpern AC, Schuchter LM, Elder DE, Guerry D. P gene as an inherited biomarker of human eye color. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 782-4. PMID 12163334  0.15
2022 El-Khoury H, Lee DJ, Alberge JB, Redd R, Cea-Curry CJ, Perry J, Barr H, Murphy C, Sakrikar D, Barnidge D, Bustoros M, Leblebjian H, Cowan A, Davis MI, Amstutz J, ... ... Rebbeck TR, et al. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study. The Lancet. Haematology. PMID 35344689 DOI: 10.1016/S2352-3026(22)00069-2  0.15
2011 Zeigler-Johnson CM, Gueye SM, Rebbeck TR. Building infrastructure for cancer research in Africa Journal Africain Du Cancer. 3: 52-58. DOI: 10.1007/s12558-010-0112-2  0.146
2021 Solsky I, Chen J, Rebbeck TR. Corrigendum to "Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations" [Gynecologic Oncology 156 (2020) 363-376]. Gynecologic Oncology. PMID 33731272 DOI: 10.1016/j.ygyno.2021.03.005  0.146
2005 Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenetics and Genomics. 15: 393-8. PMID 15900212 DOI: 10.1097/01213011-200506000-00004  0.145
2013 Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, ... ... Rebbeck TR, et al. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 508-16. PMID 23462917 DOI: 10.1158/1055-9965.Epi-13-0146  0.145
2009 Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Gallagher RP, Green AC, Gruis NA, Holly EA, Ingvar C, ... ... Rebbeck TR, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. International Journal of Epidemiology. 38: 814-30. PMID 19359257 DOI: 10.1093/ije/dyp166  0.144
2015 Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MKA, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Correction: Cancer incidence following expansion of HIV treatment in Botswana (PLoS ONE (2015) 10:9 (PLoS ONE) DOI:10.1371/journal.pone.0138742) Plos One. 10.  0.144
2020 Iyer HS, James P, Valeri L, Bajunirwe F, Nankya-Mutyoba J, Njelekela M, Chiwanga F, Sewram V, Ajayi I, Adebamowo C, Dalal S, Reid TG, Rebbeck TR, Adami HO, Holmes MD. Neighborhood greenness and burden of non-communicable diseases in Sub-Saharan Africa: A multi-country cross-sectional study. Environmental Research. 110397. PMID 33130166 DOI: 10.1016/j.envres.2020.110397  0.144
2011 Stefflova K, Dulik MC, Barnholtz-Sloan JS, Pai AA, Walker AH, Rebbeck TR. Dissecting the within-Africa ancestry of populations of African descent in the Americas. Plos One. 6: e14495. PMID 21253579 DOI: 10.1371/Journal.Pone.0014495  0.142
2019 Campbell PT, Ambrosone CB, Nishihara R, Aerts HJWL, Bondy M, Chatterjee N, Garcia-Closas M, Giannakis M, Golden JA, Heng YJ, Kip NS, Koshiol J, Liu XS, Lopes-Ramos CM, Mucci LA, ... ... Rebbeck TR, et al. Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting. Cancer Causes & Control : Ccc. PMID 31069578 DOI: 10.1007/s10552-019-01177-z  0.14
2015 Zeigler-Johnson C, Morales KH, Glanz K, Spangler E, Mitchell J, Rebbeck TR. Individual- and neighborhood-level education influences the effect of obesity on prostate cancer treatment failure after prostatectomy. Cancer Causes & Control : Ccc. PMID 26169299 DOI: 10.1007/s10552-015-0628-y  0.14
2018 Marrone MT, Tsilidis KK, Ehrhardt S, Joshu CE, Rebbeck TR, Sellers TA, Platz EA. When is enough, enough? When are more observational epidemiologic studies needed to resolve a research question: illustrations using biomarker-cancer associations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30377205 DOI: 10.1158/1055-9965.Epi-18-0660  0.14
2009 Shields PG, Sellers TA, Rebbeck TR. Null results in brief: meeting a need in changing times. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2347. PMID 19723914 DOI: 10.1158/1055-9965.Epi-09-0684  0.139
2013 Rebbeck TR, Weber AL, Spangler E, Zeigler-Johnson CM. What stresses men? Predictors of perceived stress in a population-based multi-ethnic cross sectional cohort. Bmc Public Health. 13: 113. PMID 23388399 DOI: 10.1186/1471-2458-13-113  0.139
2012 Lachance J, Vernot B, Elbers CC, Ferwerda B, Froment A, Bodo JM, Lema G, Fu W, Nyambo TB, Rebbeck TR, Zhang K, Akey JM, Tishkoff SA. Evolutionary history and adaptation from high-coverage whole-genome sequences of diverse African hunter-gatherers. Cell. 150: 457-69. PMID 22840920 DOI: 10.1016/J.Cell.2012.07.009  0.138
2014 Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, ... ... Rebbeck TR, et al. Radiogenomics: radiobiology enters the era of big data and team science. International Journal of Radiation Oncology, Biology, Physics. 89: 709-13. PMID 24969789 DOI: 10.1016/J.Ijrobp.2014.03.009  0.137
2012 Butts SF, Freeman EW, Sammel MD, Queen K, Lin H, Rebbeck TR. Joint effects of smoking and gene variants involved in sex steroid metabolism on hot flashes in late reproductive-age women. The Journal of Clinical Endocrinology and Metabolism. 97: E1032-42. PMID 22466345 DOI: 10.1210/Jc.2011-2216  0.133
2022 Iyer HS, Hart JE, James P, Elliott EG, DeVille NV, Holmes MD, De Vivo I, Mucci LA, Laden F, Rebbeck TR. Impact of neighborhood socioeconomic status, income segregation, and greenness on blood biomarkers of inflammation. Environment International. 162: 107164. PMID 35255255 DOI: 10.1016/j.envint.2022.107164  0.131
2001 Weiss MJ, Guo C, Shusterman S, Hii G, Mirensky TL, White PS, Hogarty MD, Rebbeck TR, Teare D, Urbanek M, Brodeur GM, Maris JM. Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13. Medical and Pediatric Oncology. 35: 526-30. PMID 11107108 DOI: 10.1002/1096-911X(20001201)35:6<526::Aid-Mpo5>3.0.Co;2-S  0.127
2010 Rebbeck TR, Su HI, Sammel MD, Lin H, Tran TV, Gracia CR, Freeman EW. Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition. Menopause (New York, N.Y.). 17: 1026-34. PMID 20505544 DOI: 10.1097/Gme.0B013E3181Db61A1  0.127
2022 Cicero KI, Joffe M, Patel M, Chiuzan C, Pentz A, Ruff P, Lentzsch S, Leng S, Jacobson JS, Rebbeck TR, Neugut AI. Prevalence of monoclonal gammopathy of undetermined significance in Black South African men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36126958 DOI: 10.1158/1055-9965.EPI-22-0525  0.127
2021 Marinac CR, Lee DH, Colditz GA, Rebbeck TR, Rosner B, Bustoros M, Ghobrial IM, Birmann BM. Regular Aspirin Use and Mortality in Multiple Myeloma Patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34862208 DOI: 10.1158/1055-9965.EPI-21-0946  0.126
1994 Schnur RE, Wick PA, Bailey C, Rebbeck T, Weleber RG, Wagstaff J, Grix AW, Pagon RA, Hockey A, Edwards MJ. Phenotypic variability in X-linked ocular albinism: Relationship to linkage genotypes American Journal of Human Genetics. 55: 484-496. PMID 7915878  0.126
1998 Viana MAG, Rogatko A, Rebbeck TR. Statistical assessment of multivalued screening tests Canadian Journal of Statistics. 26: 657-668.  0.125
2015 Davies JR, Chang YM, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green A, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, ... ... Rebbeck TR, et al. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 817-24. PMID 25713022 DOI: 10.1158/1055-9965.Epi-14-1062  0.125
2002 Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers European Journal of Cancer. 38. PMID 12409058 DOI: 10.1016/S0959-8049(02)80012-0  0.125
2004 Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick MR. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases Cancer Causes and Control. 15: 957-965. DOI: 10.1007/s10552-004-2474-1  0.124
2018 Marinac CR, Birmann BM, Lee IM, Rosner BA, Townsend MK, Giovannucci E, Rebbeck TR, Buring JE, Colditz GA. Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts. British Journal of Cancer. PMID 29527008 DOI: 10.1038/s41416-018-0010-4  0.121
2024 Castle PE, Faupel-Badger JM, Umar A, Rebbeck TR. A Proposed Framework and Lexicon for Cancer Prevention. Cancer Discovery. 14: 594-599. PMID 38571411 DOI: 10.1158/2159-8290.CD-23-1492  0.12
2012 Kimmel SE, Leufkens HG, Rebbeck TR. Molecular Pharmacoepidemiology Pharmacoepidemiology, Fifth Edition. 601-622. DOI: 10.1002/9781119959946.ch34  0.119
Hide low-probability matches.